Briard, B., Place, D. E. & Kanneganti, T. D. DNA Sensing in the Innate Immune Response. Physiol. (Bethesda) 35, 112–124 (2020).
Liu, G. & Gack, M. U. Distinct and orchestrated functions of RNA sensors in innate immunity. Immunity 53, 26–42 (2020).
Okude, H., Ori, D. & Kawai, T. Signaling through nucleic acid sensors and their roles in inflammatory diseases. Front. Immunol. 11, 625833 (2020).
McWhirter, S. M. & Jefferies, C. A. Nucleic acid sensors as therapeutic targets for human disease. Immunity 53, 78–97 (2020).
Kwak, H., Lee, E. & Karki, R. DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects. Immunol. Rev. 329, e13382 (2025).
Miller, K. N. et al. Cytoplasmic DNA: sources, sensing, and role in aging and disease. Cell 184, 5506–5526 (2021).
Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B. Biol. Sci. 147, 258–267 (1957).
Rotem, Z., Cox, R. A. & Isaacs, A. Inhibition of virus multiplication by foreign nucleic acid. Nature 197, 564–566 (1963).
Isaacs, A. Particle counts and infectivity titrations for animal viruses. Adv. Virus Res. 4, 111–158 (1957).
Lindenmann, J., Burke, D. C. & Isaacs, A. Studies on the production, mode of action and properties of interferon. Br. J. Exp. Pathol. 38, 551–562 (1957).
Isaacs, A., Cox, R. A. & Rotem, Z. Foreign nucleic acids as the stimulus to make interferon. Lancet 2, 113–116 (1963).
Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740–745 (2000).
Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674–678 (2008).
Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538–550 (2008).
Jin, L. et al. MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol. Cell. Biol. 28, 5014–5026 (2008).
Sun, W. et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl Acad. Sci. USA 106, 8653–8658 (2009).
Roberts, T. L. et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323, 1057–1060 (2009).
Fernandes-Alnemri, T. et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509–513 (2009).
Bürckstümmer, T. et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10, 266–272 (2009).
Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518 (2009).
Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826–830 (2013).
Sun, L. et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786–791 (2013).
Hovanessian, A. G., Brown, R. E. & Kerr, I. M. Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature 268, 537–540 (1977).
Zilberstein, A., Kimchi, A., Schmidt, A. & Revel, M. Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proc. Natl Acad. Sci. Usa. 75, 4734–4738 (1978).
Clemens, M. J. PKR—A protein kinase regulated by double-stranded RNA. Int. J. Biochem. Cell Biol. 29, 945–949 (1997).
Farrell, P. J. et al. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc. Natl Acad. Sci. USA 75, 5893–5897 (1978).
Minks, M. A., West, D. K., Benvin, S. & Baglioni, C. Structural requirements of double-stranded RNA for the activation of 2’,5’-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J. Biol. Chem. 254, 10180–10183 (1979).
Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732–738 (2001).
Yamamoto, M. et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668–6672 (2002).
Oshiumi, H. et al. TICAM-1, an adaptor molecule that participates in toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4, 161–167 (2003).
Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640–643 (2003).
Hoebe, K. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743–748 (2003).
Heil, F. et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526–1529 (2004).
Diebold, S. S. et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529–1531 (2004).
Lund, J. M. et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl Acad. Sci. USA 101, 5598–5603 (2004).
Hemmi, H. et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3, 196–200 (2002).
Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335–376 (2003).
Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730–737 (2004).
Hornung, V. et al. 5’-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006).
Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105 (2006).
Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates. Science 314, 997–1001 (2006).
Kato, H. et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19–28 (2005).
Yoneyama, M. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175, 2851–2858 (2005).
Pippig, D. A. et al. The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA. Nucleic Acids Res 37, 2014–2025 (2009).
Li, X. et al. The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J. Biol. Chem. 284, 13881–13891 (2009).
Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669–682 (2005).
Xu, L. G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727–740 (2005).
Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172 (2005).
Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981–988 (2005).
Daffis, S. et al. 2’-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468, 452–456 (2010).
Pichlmair, A. et al. IFIT1 is an antiviral protein that recognizes 5’-triphosphate RNA. Nat. Immunol. 12, 624–630 (2011).
Bauernfried, S. et al. Human NLRP1 is a sensor for double-stranded RNA. Science 371, eabd0811 (2021).
Chan, M. P. et al. DNase II-dependent DNA digestion is required for DNA sensing by TLR9. Nat. Commun. 6, 5853 (2015).
Bauer, S. et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl Acad. Sci. Usa. 98, 9237–9242 (2001).
Hornung, V. et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531–4537 (2002).
Hayashi, F., Means, T. K. & Luster, A. D. Toll-like receptors stimulate human neutrophil function. Blood 102, 2660–2669 (2003).
Aslam, R. et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107, 637–641 (2006).
Hotz, M. J. et al. Red blood cells homeostatically bind mitochondrial DNA through TLR9 to maintain quiescence and to prevent lung injury. Am. J. Respir. Crit. Care Med. 197, 470–480 (2018).
Lam, L. K. M. et al. DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia. Sci. Transl. Med. 13, eabj1008 (2021).
Leifer, C. A. et al. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 173, 1179–1183 (2004).
Chockalingam, A. et al. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunol. Cell Biol. 87, 209–217 (2009).
Ewald, S. E. et al. The ectodomain of toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456, 658–662 (2008).
Onji, M. et al. An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing. Nat. Commun. 4, 1949 (2013).
Huang, X. & Yang, Y. Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses. Expert Opin. Ther. Targets 14, 787–796 (2010).
Cardon, L. R., Burge, C., Clayton, D. A. & Karlin, S. Pervasive CpG suppression in animal mitochondrial genomes. Proc. Natl Acad. Sci. USA 91, 3799–3803 (1994).
Riley, J. S. & Tait, S. W. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 21, e49799 (2020).
Uematsu, S. & Akira, S. Toll-like receptors and Type I interferons. J. Biol. Chem. 282, 15319–15323 (2007).
Kawai, T. et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5, 1061–1068 (2004).
Honda, K. et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl Acad. Sci. USA 101, 15416–15421 (2004).
Uematsu, S. et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J. Exp. Med. 201, 915–923 (2005).
Negishi, H. et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc. Natl Acad. Sci. USA 103, 15136–15141 (2006).
Schmitz, F. et al. Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur. J. Immunol. 37, 315–327 (2007).
Kawai, T. & Akira, S. Signaling to NF-kappaB by toll-like receptors. Trends Mol. Med. 13, 460–469 (2007).
Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087–1095 (2005).
Hopfner, K. P. & Hornung, V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nat. Rev. Mol. Cell Biol. 21, 501–521 (2020).
Barber, G. N. STING: infection, inflammation and cancer. Nat. Rev. Immunol. 15, 760–770 (2015).
Ablasser, A. et al. cGAS produces a 2’-5’-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380–384 (2013).
Bode, C. et al. Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway. Eur. J. Immunol. 46, 1615–1621 (2016).
Civril, F. et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498, 332–337 (2013).
Andreeva, L. et al. cGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders. Nature 549, 394–398 (2017).
Herzner, A. M. et al. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nat. Immunol. 16, 1025–1033 (2015).
Ablasser, A. & Chen, Z. J. cGAS in action: Expanding roles in immunity and inflammation. Science 363, eaat8657 (2019).
Gao, P. et al. Cyclic [G(2’,5’)pA(3’,5’)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153, 1094–1107 (2013).
Li, T. et al. Phosphorylation and chromatin tethering prevent cGAS activation during mitosis. Science 371, eabc5386 (2021).
Volkman, H. E., Cambier, S., Gray, E. E. & Stetson, D. B. Tight nuclear tethering of cGAS is essential for preventing autoreactivity. Elife 8, e47491 (2019).
Shang, G. et al. Crystal structures of STING protein reveal basis for recognition of cyclic di-GMP. Nat. Struct. Mol. Biol. 19, 725–727 (2012).
Zhang, C. et al. Structural basis of STING binding with and phosphorylation by TBK1. Nature 567, 394–398 (2019).
Ishikawa, H., Ma, Z. & Barber, G. N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788–792 (2009).
Tanaka, Y. & Chen, Z. J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal. 5, ra20 (2012).
Liu, S. et al. Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation. Science 347, aaa2630 (2015).
Zhao, B. et al. A conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1. Nature 569, 718–722 (2019).
Abe, T. & Barber, G. N. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1. J. Virol. 88, 5328–5341 (2014).
Gui, X. et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature 567, 262–266 (2019).
Paludan, S. R., Reinert, L. S. & Hornung, V. DNA-stimulated cell death: Implications for host defence, inflammatory diseases and cancer. Nat. Rev. Immunol. 19, 141–153 (2019).
Ma, C. et al. AIM2 controls microglial inflammation to prevent experimental autoimmune encephalomyelitis. J. Exp. Med. 218, e20201796 (2021).
Lozano-Ruiz, B. et al. Absent in Melanoma 2 (AIM2) Regulates the Stability of Regulatory T Cells. Int. J. Mol. Sci. 23, 2230 (2022).
Svensson, A. et al. Maturation-dependent expression of AIM2 in human B-cells. PLoS One 12, e0183268 (2017).
Marchesan, J. T. et al. Common polymorphisms in IFI16 and AIM2 genes are associated with periodontal disease. J. Periodontol. 88, 663–672 (2017).
Sharma, M. & de Alba, E. Structure, activation and regulation of NLRP3 and AIM2 inflammasomes. Int. J. Mol. Sci. 22, 872 (2021).
Jin, T. et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36, 561–571 (2012).
Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015).
Zhu, W., Zu, X., Liu, S. & Zhang, H. The absent in melanoma 2 (AIM2) inflammasome in microbial infection. Clin. Chim. Acta 495, 100–108 (2019).
Karki, R. et al. Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection. Cell Host Microbe 17, 357–368 (2015).
Sharma, B. R., Karki, R. & Kanneganti, T. D. Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur. J. Immunol. 49, 1998–2011 (2019).
Di Micco, A. et al. AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity. Proc. Natl Acad. Sci. USA 113, E4671–E4680 (2016).
Kumari, P., Russo, A. J., Shivcharan, S. & Rathinam, V. A. AIM2 in health and disease: Inflammasome and beyond. Immunol. Rev. 297, 83–95 (2020).
Fang, R. et al. Type I interferon signaling regulates activation of the absent in melanoma 2 inflammasome during Streptococcus pneumoniae infection. Infect. Immun. 82, 2310–2317 (2014).
Henry, T. et al. Type I interferon signaling is required for activation of the inflammasome during Francisella infection. J. Exp. Med. 204, 987–994 (2007).
Yan, S. et al. Deficiency of the AIM2-ASC signal uncovers the STING-driven overreactive response of type I IFN and reciprocal depression of protective IFN-γ immunity in mycobacterial infection. J. Immunol. 200, 1016–1026 (2018).
Corrales, L. et al. Antagonism of the STING pathway via activation of the AIM2 inflammasome by intracellular DNA. J. Immunol. 196, 3191–3198 (2016).
Wang, Y. et al. Inflammasome activation triggers caspase-1-mediated cleavage of cGAS to regulate responses to DNA virus infection. Immunity 46, 393–404 (2017).
Steinhagen, F. et al. Suppressive oligodeoxynucleotides containing TTAGGG motifs inhibit cGAS activation in human monocytes. Eur. J. Immunol. 48, 605–611 (2018).
Kaminski, J. J. et al. Synthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation. J. Immunol. 191, 3876–3883 (2013).
Unterholzner, L. et al. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11, 997–1004 (2010).
Zhang, Z. et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12, 959–965 (2011).
Lee, K. G. et al. Bruton’s tyrosine kinase phosphorylates DDX41 and activates its binding of dsDNA and STING to initiate type 1 interferon response. Cell Rep. 10, 1055–1065 (2015).
Chen, W. et al. DNA sensor IFI204 contributes to host defense against staphylococcus aureus infection in mice. Front. Immunol. 10, 474 (2019).
Piccaluga, P. P. et al. IFI16 expression is related to selected transcription factors during B-cell differentiation. J. Immunol. Res. 2015, 747645 (2015).
Tamassia, N. et al. IFN-β expression is directly activated in human neutrophils transfected with plasmid DNA and is further increased via TLR-4-mediated signaling. J. Immunol. 189, 1500–1509 (2012).
Wei, W. et al. Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem. Cell Biol. 119, 45–54 (2003).
Gariglio, M. et al. The murine homolog of the HIN 200 family, Ifi 204, is constitutively expressed in myeloid cells and selectively induced in the monocyte/macrophage lineage. J. Leukoc. Biol. 64, 608–614 (1998).
Morrone, S. R. et al. Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy. Proc. Natl Acad. Sci. USA 111, E62–E71 (2014).
Kerur, N. et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe 9, 363–375 (2011).
Li, T., Diner, B. A., Chen, J. & Cristea, I. M. Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc. Natl Acad. Sci. USA 109, 10558–10563 (2012).
Jiang, Y., Zhu, Y., Liu, Z. J. & Ouyang, S. The emerging roles of the DDX41 protein in immunity and diseases. Protein Cell 8, 83–89 (2017).
Polprasert, C. et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell 27, 658–670 (2015).
Parvatiyar, K. et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 13, 1155–1161 (2012).
Ponnusamy, K. et al. The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma. Haematologica 107, 721–732 (2022).
Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501–505 (2007).
Song, Q., Fan, Y., Zhang, H. & Wang, N. Z-DNA binding protein 1 orchestrates innate immunity and inflammatory cell death. Cytokine Growth Factor Rev. 77, 15–29 (2024).
Lei, Y. et al. Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity. Cell 186, 3013–3032.e3022 (2023).
Benmerzoug, S., Ryffel, B., Togbe, D. & Quesniaux, V. F. J. Self-DNA sensing in lung inflammatory diseases. Trends Immunol. 40, 719–734 (2019).
Hornung, V. et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263–270 (2005).
Kawai, T., Ikegawa, M., Ori, D. & Akira, S. Decoding toll-like receptors: Recent insights and perspectives in innate immunity. Immunity 57, 649–673 (2024).
Matsumoto, M. et al. Subcellular localization of toll-like receptor 3 in human dendritic cells. J. Immunol. 171, 3154–3162 (2003).
Shibata, T. et al. Guanosine and its modified derivatives are endogenous ligands for TLR7. Int. Immunol. 28, 211–222 (2016).
Tanji, H. et al. Toll-like receptor 8 senses degradation products of single-stranded RNA. Nat. Struct. Mol. Biol. 22, 109–115 (2015).
Ostendorf, T. et al. Immune sensing of synthetic, bacterial, and protozoan RNA by toll-like receptor 8 requires coordinated processing by RNase T2 and RNase 2. Immunity 52, 591–605.e596 (2020).
Greulich, W. et al. TLR8 is a sensor of RNase T2 degradation products. Cell 179, 1264–1275.e1213 (2019).
Bérouti, M. et al. Lysosomal endonuclease RNase T2 and PLD exonucleases cooperatively generate RNA ligands for TLR7 activation. Immunity 57, 1482–1496.e1488 (2024).
Tong, A. J. et al. Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage. J. Exp. Med. 221 (2024).
Leonard, J. N. et al. The TLR3 signaling complex forms by cooperative receptor dimerization. Proc. Natl Acad. Sci. Usa. 105, 258–263 (2008).
Kleinman, M. E. et al. Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol. Ther. 20, 101–108 (2012).
Weber, C. et al. Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology 136, 64–77 (2012).
Peisley, A. et al. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Cell 51, 573–583 (2013).
Wu, B. et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 152, 276–289 (2013).
Luo, D. et al. Structural insights into RNA recognition by RIG-I. Cell 147, 409–422 (2011).
Kowalinski, E. et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147, 423–435 (2011).
Sharma, S. et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148–1151 (2003).
Fitzgerald, K. A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491–496 (2003).
Rothenfusser, S. et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175, 5260–5268 (2005).
Satoh, T. et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc. Natl Acad. Sci. USA 107, 1512–1517 (2010).
Schlee, M. et al. Recognition of 5’ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31, 25–34 (2009).
Kato, H. et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205, 1601–1610 (2008).
Pestal, K. et al. Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development. Immunity 43, 933–944 (2015).
Liddicoat, B. J. et al. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349, 1115–1120 (2015).
Stok, J. E. et al. RNA sensing via the RIG-I-like receptor LGP2 is essential for the induction of a type I IFN response in ADAR1 deficiency. EMBO J. 41, e109760 (2022).
Habjan, M. et al. Sequestration by IFIT1 impairs translation of 2’O-unmethylated capped RNA. PLoS Pathog. 9, e1003663 (2013).
Tokunaga, T. et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J. Natl Cancer Inst. 72, 955–962 (1984).
Yamamoto, S. et al. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. J. Immunol. 148, 4072–4076 (1992).
Krieg, A. M. et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546–549 (1995).
Zahid, A., Ismail, H., Li, B. & Jin, T. Molecular and structural basis of DNA sensors in antiviral innate immunity. Front. Immunol. 11, 613039 (2020).
Aucamp, J., Bronkhorst, A. J., Badenhorst, C. P. S. & Pretorius, P. J. The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature. Biol. Rev. Camb. Philos. Soc. 93, 1649–1683 (2018).
Liu, N., Pang, X., Zhang, H. & Ji, P. The cGAS-STING pathway in bacterial infection and bacterial immunity. Front. Immunol. 12, 814709 (2021).
Rodriguez, B. V. & Kuehn, M. J. Staphylococcus aureus secretes immunomodulatory RNA and DNA via membrane vesicles. Sci. Rep. 10, 18293 (2020).
Kaewduangduen, W. et al. Blood bacteria-free DNA in septic mice enhances LPS-induced inflammation in mice through macrophage response. Int. J. Mol. Sci. 23, 1907 (2022).
Cheng, Z. et al. The central role and possible mechanisms of bacterial DNAs in sepsis development. Med. Inflamm. 2020, 7418342 (2020).
Gosiewski, T. et al. Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method – the observation of DNAemia. Eur. J. Clin. Microbiol. Infect. Dis. 36, 329–336 (2017).
Zhu, L., Qi, Z., Zhang, H. & Wang, N. Nucleic Acid Sensor-Mediated PANoptosis in Viral Infection. Viruses 16, 966 (2024).
Ma, Z., Ni, G. & Damania, B. Innate sensing of DNA virus genomes. Annu Rev. Virol. 5, 341–362 (2018).
Lee, H. C., Chathuranga, K. & Lee, J. S. Intracellular sensing of viral genomes and viral evasion. Exp. Mol. Med. 51, 1–13 (2019).
Ramirez-Ortiz, Z. G. et al. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect. Immun. 76, 2123–2129 (2008).
Kausar, S. et al. Mitochondrial DNA: A Key Regulator of Anti-Microbial Innate Immunity. Genes (Basel) 11, 86 (2020).
Sato, Y. & Hayashi, M. T. Micronucleus is not a potent inducer of the cGAS/STING pathway. Life Sci. Alliance 7, e202302424 (2024).
Takaki, T., Millar, R., Hiley, C. T. & Boulton, S. J. Micronuclei induced by radiation, replication stress, or chromosome segregation errors do not activate cGAS-STING. Mol. Cell 84, 2203–2213.e2205 (2024).
Lebrec, V. et al. A microscopy reporter for cGAMP reveals rare cGAS activation following DNA damage, and a lack of correlation with micronuclear cGAS enrichment. Preprint at https://www.biorxiv.org/content/10.1101/2024.05.13.593978v1 (2024).
Patrushev, M. et al. Mitochondrial permeability transition triggers the release of mtDNA fragments. Cell. Mol. Life Sci. 61, 3100–3103 (2004).
Nerlich, A. et al. Pneumolysin induced mitochondrial dysfunction leads to release of mitochondrial DNA. Sci. Rep. 8, 182 (2018).
Cosentino, K. et al. The interplay between BAX and BAK tunes apoptotic pore growth to control mitochondrial-DNA-mediated inflammation. Mol. Cell 82, 933–949.e939 (2022).
Kim, J. et al. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science 366, 1531–1536 (2019).
Cosentino, K. & García-Sáez, A. J. Bax and bak pores: Are we closing the circle? Trends Cell Biol. 27, 266–275 (2017).
Varughese, J. T., Buchanan, S. K. & Pitt, A. S. The role of voltage-dependent anion channel in mitochondrial dysfunction and human disease. Cells 10, 1737 (2021).
White, M. J. et al. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell 159, 1549–1562 (2014).
Rongvaux, A. et al. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell 159, 1563–1577 (2014).
Hu, H., Guo, L., Overholser, J. & Wang, X. Mitochondrial VDAC1: a potential therapeutic target of inflammation-related diseases and clinical opportunities. Cells 11, 3174 (2022).
Gao, Y. et al. Mitochondrial DNA leakage caused by streptococcus pneumoniae hydrogen peroxide promotes type I IFN expression in lung cells. Front. Microbiol. 10, 630 (2019).
Guarnieri, J. W. et al. SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19. Pharmacol. Res. 204, 107170 (2024).
Zhao, M. et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics 11, 1845–1863 (2021).
Kirsch-Volders, M. & Fenech, M. Inflammatory cytokine storms severity may be fueled by interactions of micronuclei and RNA viruses such as COVID-19 virus SARS-CoV-2. A hypothesis. Mutat. Res. Rev. Mutat. Res. 788, 108395 (2021).
Ku, J. W. K. et al. Bacterial-induced cell fusion is a danger signal triggering cGAS-STING pathway via micronuclei formation. Proc. Natl Acad. Sci. USA 117, 15923–15934 (2020).
Buchrieser, J. et al. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 39, e106267 (2020).
Moss, J. et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat. Commun. 9, 5068 (2018).
Ljungman, P. et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin. Infect. Dis. 64, 87–91 (2017).
Elkon, K. B. Review: Cell death, nucleic acids, and immunity: Inflammation beyond the grave. Arthritis Rheumatol. 70, 805–816 (2018).
Thiam, H. R., Wong, S. L., Wagner, D. D. & Waterman, C. M. Cellular mechanisms of NETosis. Annu. Rev. Cell Dev. Biol. 36, 191–218 (2020).
Grabuschnig, S. et al. Putative origins of cell-free DNA in humans: A review of active and passive nucleic acid release mechanisms. Int. J. Mol. Sci. 21, 8062 (2020).
Elzanowska, J., Semira, C. & Costa-Silva, B. DNA in extracellular vesicles: biological and clinical aspects. Mol. Oncol. 15, 1701–1714 (2021).
Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).
van Niel, G., D’Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228 (2018).
Battistelli, M. & Falcieri, E. Apoptotic bodies: Particular extracellular vesicles involved in intercellular communication. Biology (Basel) 9, 21 (2020).
Fernando, M. R., Jiang, C., Krzyzanowski, G. D. & Ryan, W. L. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS One 12, e0183915 (2017).
Ghanam, J. et al. DNA in extracellular vesicles: from evolution to its current application in health and disease. Cell Biosci. 12, 37 (2022).
Malkin, E. Z. & Bratman, S. V. Bioactive DNA from extracellular vesicles and particles. Cell Death Dis. 11, 584 (2020).
Saari, H. et al. Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery. J. Extracell. Vesicles 9, 1747206 (2020).
Lécrivain, A. L. & Beckmann, B. M. Bacterial RNA in extracellular vesicles: A new regulator of host-pathogen interactions? Biochim. Biophys. Acta Gene Regul. Mech. 1863, 194519 (2020).
Zhou, Y. K., Patel, H. H. & Roth, D. M. Extracellular vesicles: A new paradigm for cellular communication in perioperative medicine, critical care, and pain management. Anesth. Analg. 133, 1162–1179 (2021).
An, N., Chen, Z., Zhao, P. & Yin, W. Extracellular vesicles in sepsis: Pathogenic roles, organ damage, and therapeutic implications. Int. J. Med. Sci. 20, 1722–1731 (2023).
Su, P. et al. A review of extracellular vesicles in COVID-19 diagnosis, treatment, and prevention. Adv. Sci. (Weinh.) 10, e2206095 (2023).
Blander, J. M. The many ways tissue phagocytes respond to dying cells. Immunol. Rev. 277, 158–173 (2017).
Lou, H. & Pickering, M. C. Extracellular DNA and autoimmune diseases. Cell. Mol. Immunol. 15, 746–755 (2018).
Nozaki, K., Li, L. & Miao, E. A. Innate sensors trigger regulated cell death to combat intracellular infection. Annu. Rev. Immunol. 40, 469–498 (2022).
Maelfait, J., Liverpool, L. & Rehwinkel, J. Nucleic acid sensors and programmed cell death. J. Mol. Biol. 432, 552–568 (2020).
Cristiano, S. et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 570, 385–389 (2019).
Gielis, E. M. et al. Cell-Free DNA: An upcoming biomarker in transplantation. Am. J. Transplant. 15, 2541–2551 (2015).
Fan, H. C. et al. Non-invasive prenatal measurement of the fetal genome. Nature 487, 320–324 (2012).
Jin, X. et al. Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19. Mol. Genet. Genomics 298, 823–836 (2023).
Zhang, H. et al. Fragmentomics of plasma mitochondrial and nuclear DNA inform prognosis in COVID-19 patients with critical symptoms. BMC Med. Genomics 17, 243 (2024).
Jing, Q., Leung, C. H. C. & Wu, A. R. Cell-free DNA as biomarker for sepsis by integration of microbial and host information. Clin. Chem. 68, 1184–1195 (2022).
You, R. et al. A promising application of kidney-specific cell-free DNA methylation markers in real-time monitoring sepsis-induced acute kidney injury. Epigenetics 19, 2408146 (2024).
Fujihara, J. et al. Circulating cell-free DNA fragment analysis by microchip electrophoresis and its relationship with DNase I in cardiac diseases. Clin. Chim. Acta 497, 61–66 (2019).
Soni, C. & Reizis, B. DNA as a self-antigen: Nature and regulation. Curr. Opin. Immunol. 55, 31–37 (2018).
Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487–496 (2007).
Liu, Y. et al. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. J. Hepatol. 63, 114–121 (2015).
Young, M. D. et al. Circulatory HMGB1 is an early predictive and prognostic biomarker of ARDS and mortality in a swine model of polytrauma. Front. Immunol. 14, 1227751 (2023).
Deng, C. et al. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. Acta Pharmacol. Sin. 43, 520–528 (2022).
Foglio, E., Pellegrini, L., Russo, M. A. & Limana, F. HMGB1-mediated activation of the inflammatory-reparative response following myocardial infarction. Cells 11, 216 (2022).
Marchi, S. et al. Mitochondrial control of inflammation. Nat. Rev. Immunol. 23, 159–173 (2023).
Liu, H. et al. TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic mitochondrial DNA. Nat. Cell Biol. 26, 878–891 (2024).
Ivanov, S. et al. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110, 1970–1981 (2007).
Liu, L. et al. HMGB1-DNA complex-induced autophagy limits AIM2 inflammasome activation through RAGE. Biochem. Biophys. Res. Commun. 450, 851–856 (2014).
Trumpff, C. et al. Stress and circulating cell-free mitochondrial DNA: A systematic review of human studies, physiological considerations, and technical recommendations. Mitochondrion 59, 225–245 (2021).
Mihaljevic, O. et al. Oxidative stress and DNA damage in critically ill patients with sepsis. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 889, 503655 (2023).
Ermakov, A. V. et al. Oxidized extracellular DNA as a stress signal in human cells. Oxid. Med. Cell. Longev. 2013, 649747 (2013).
Moriyama, M. et al. Influenza Virus-Induced Oxidized DNA Activates Inflammasomes. iScience 23, 101270 (2020).
Xian, H. et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 54, 1463–1477.e1411 (2021).
Xian, H. et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity 55, 1370–1385.e1378 (2022).
Xu, J. et al. MLKL deficiency attenuated hepatocyte oxidative DNA damage by activating mitophagy to suppress macrophage cGAS-STING signaling during liver ischemia and reperfusion injury. Cell Death Discov. 9, 58 (2023).
Andargie, T. E. et al. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight 6, e147610 (2021).
Cheng, A. P. et al. Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity. Med 2, 411–422.e415 (2021).
Zemmour, H. et al. Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA. Nat. Commun. 9, 1443 (2018).
Szilágyi, M. et al. Circulating cell-free nucleic acids: Main characteristics and clinical application. Int. J. Mol. Sci. 21, 6827 (2020).
Kim, K. M. et al. RNA in extracellular vesicles. Wiley Interdiscip. Rev. RNA 8, 10.1002/wrna.1413 (2017).
Weber, F. et al. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80, 5059–5064 (2006).
Schlee, M. & Hartmann, G. Discriminating self from non-self in nucleic acid sensing. Nat. Rev. Immunol. 16, 566–580 (2016).
Rehwinkel, J. et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140, 397–408 (2010).
Strähle, L. et al. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J. Virol. 81, 12227–12237 (2007).
Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522–1527 (2007).
Préhaud, C., Mégret, F., Lafage, M. & Lafon, M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79, 12893–12904 (2005).
Rasmussen, S. B. et al. Herpes simplex virus infection is sensed by both Toll-like receptors and retinoic acid-inducible gene- like receptors, which synergize to induce type I interferon production. J. Gen. Virol. 90, 74–78 (2009).
Li, H. et al. Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells. Immunology 117, 167–176 (2006).
Hu, S. B. et al. ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation. Mol. Cell 83, 3869–3884.e3867 (2023).
Chung, H. et al. Human ADAR1 prevents endogenous RNA from triggering translational shutdown. Cell 172, 811–824.e814 (2018).
Sinigaglia, K. et al. An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation. Cell Rep. 43, 114618 (2024).
de Regt, A. K. et al. A conserved isoleucine in the binding pocket of RIG-I controls immune tolerance to mitochondrial RNA. Nucleic Acids Res 51, 11893–11910 (2023).
Schuberth-Wagner, C. et al. A conserved histidine in the RNA sensor RIG-I controls immune tolerance to N1-2’O-methylated self RNA. Immunity 43, 41–51 (2015).
Anderson, S. et al. Sequence and organization of the human mitochondrial genome. Nature 290, 457–465 (1981).
Rossmanith, W. Of P and Z: mitochondrial tRNA processing enzymes. Biochim. Biophys. Acta 1819, 1017–1026 (2012).
Mai, N., Chrzanowska-Lightowlers, Z. M. & Lightowlers, R. N. The process of mammalian mitochondrial protein synthesis. Cell Tissue Res 367, 5–20 (2017).
Dhir, A. et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560, 238–242 (2018).
Kim, Y. et al. PKR senses nuclear and mitochondrial signals by interacting with endogenous double-stranded RNAs. Mol. Cell 71, 1051–1063.e1056 (2018).
Villegas, J. et al. Expression of a novel non-coding mitochondrial RNA in human proliferating cells. Nucleic Acids Res 35, 7336–7347 (2007).
Bellani, G. et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315, 788–800 (2016).
Luyt, C. E. et al. Pulmonary infections complicating ARDS. Intensive Care Med. 46, 2168–2183 (2020).
Umbrello, M., Formenti, P., Bolgiaghi, L. & Chiumello, D. Current concepts of ARDS: A narrative review. Int. J. Mol. Sci. 18, 64 (2016).
Tasaka, S. et al. Intratracheal synthetic CpG oligodeoxynucleotide causes acute lung injury with systemic inflammatory response. Respir. Res. 10, 84 (2009).
Knuefermann, P. et al. CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo. Respir. Res. 8, 72 (2007).
Itagaki, K. et al. Bacterial DNA induces pulmonary damage via TLR-9 through cross-talk with neutrophils. Shock 36, 548–552 (2011).
Dreschler, K. et al. Altered phenotype of blood dendritic cells in patients with acute pneumonia. Respiration 83, 209–217 (2012).
van der Meer, A. J. et al. Toll-like receptor 9 enhances bacterial clearance and limits lung consolidation in murine pneumonia caused by methicillin resistant Staphylococcus aureus. Mol. Med. 22, 292–299 (2016).
Bhan, U. et al. Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila. Infect. Immun. 76, 2895–2904 (2008).
Benmohamed, F. et al. Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infection. PLoS One 9, e90466 (2014).
Liu, B. C. et al. Constitutive interferon maintains GBP expression required for release of bacterial components upstream of pyroptosis and anti-DNA responses. Cell Rep. 24, 155–168.e155 (2018).
Ruiz-Moreno, J. S. et al. The common HAQ STING variant impairs cGAS-dependent antibacterial responses and is associated with susceptibility to Legionnaires’ disease in humans. PLoS Pathog. 14, e1006829 (2018).
Ruiz-Moreno, J. S. et al. The cGAS/STING pathway detects streptococcus pneumoniae but appears dispensable for antipneumococcal defense in mice and humans. Infect. Immun. 86 (2018).
Koppe, U. et al. Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs. J. Immunol. 188, 811–817 (2012).
Hu, X. et al. Type I IFN expression is stimulated by cytosolic MtDNA released from pneumolysin-damaged mitochondria via the STING signaling pathway in macrophages. FEBS J. 286, 4754–4768 (2019).
Liu, Z. Z. et al. STING contributes to host defense against staphylococcus aureus pneumonia through suppressing necroptosis. Front. Immunol. 12, 636861 (2021).
Peukert, K. et al. Inhibition of caspase-1 with tetracycline ameliorates acute lung injury. Am. J. Respir. Crit. Care Med. 204, 53–63 (2021).
Fang, R. et al. Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J. Immunol. 187, 4890–4899 (2011).
Li, H. et al. Neutrophil extracellular traps augmented alveolar macrophage pyroptosis via AIM2 inflammasome activation in LPS-induced ALI/ARDS. J. Inflamm. Res. 14, 4839–4858 (2021).
Parker, D. et al. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. mBio 2, e00016–00011 (2011).
Suresh, M. V. et al. TLR3 absence confers increased survival with improved macrophage activity against pneumonia. JCI Insight 4, e131195 (2019).
Spelmink, L. et al. Toll-like receptor 3/TRIF-dependent IL-12p70 secretion mediated by streptococcus pneumoniae RNA and its priming by influenza A virus coinfection in human dendritic cells. mBio 7, e00168–00116 (2016).
Pennetzdorfer, N. et al. Bacterial outer membrane vesicles bound to bacteriophages modulate neutrophil responses to bacterial infection. Front. Cell. Infect. Microbiol. 13, 1250339 (2023).
Xu, H. et al. Absence of Toll-like receptor 7 protects mice against Pseudomonas aeruginosa pneumonia. Int. Immunopharmacol. 96, 107739 (2021).
Moen, S. H. et al. Human toll-like receptor 8 (TLR8) is an important sensor of pyogenic bacteria, and is attenuated by cell surface TLR signaling. Front. Immunol. 10, 1209 (2019).
Bergstrøm, B. et al. TLR8 senses staphylococcus aureus RNA in human primary monocytes and macrophages and induces IFN-β production via a TAK1-IKKβ-IRF5 signaling pathway. J. Immunol. 195, 1100–1111 (2015).
Ehrnström, B. et al. Toll-like receptor 8 is a major sensor of group B streptococcus but not escherichia coli in human primary monocytes and macrophages. Front. Immunol. 8, 1243 (2017).
Martínez, I. et al. Apoptosis, toll-like, RIG-I-like and NOD-like receptors are pathways jointly induced by diverse respiratory bacterial and viral pathogens. Front. Microbiol. 8, 276 (2017).
Monroe, K. M., McWhirter, S. M. & Vance, R. E. Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog. 5, e1000665 (2009).
Opitz, B. et al. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J. Biol. Chem. 281, 36173–36179 (2006).
Kalil, A. C. & Thomas, P. G. Influenza virus-related critical illness: Pathophysiology and epidemiology. Crit. Care 23, 258 (2019).
Lee, N. et al. Role of human Toll-like receptors in naturally occurring influenza A infections. Influenza Other Respir. Viruses 7, 666–675 (2013).
Martínez-Colón, G. J. et al. Influenza-induced immune suppression to methicillin-resistant Staphylococcus aureus is mediated by TLR9. PLoS Pathog. 15, e1007560 (2019).
Rich, H. E. A. et al. TLR9 knockout in non-hematopoietic cells protects mice from influenza/MRSA super-infection. J. Immunol. 206, 110.101–110.101 (2021).
Root-Bernstein, R. Innate receptor activation patterns involving TLR and NLR synergisms in COVID-19, ALI/ARDS and sepsis cytokine storms: A review and model making novel predictions and therapeutic suggestions. Int. J. Mol. Sci. 22, 2108 (2021).
Lv, N. et al. Dysfunctional telomeres through mitostress-induced cGAS/STING activation to aggravate immune senescence and viral pneumonia. Aging Cell 21, e13594 (2022).
Moriyama, M., Koshiba, T. & Ichinohe, T. Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses. Nat. Commun. 10, 4624 (2019).
Holm, C. K. et al. Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses. Nat. Commun. 7, 10680 (2016).
King, C. R. et al. Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection. Cell Host Microbe 31, 1552–1567.e1558 (2023).
Messaoud-Nacer, Y. et al. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS). Cell Death Dis. 13, 269 (2022).
Xu, D. W. & Tate, M. D. Taking AIM at influenza: The role of the AIM2 inflammasome. Viruses 16, 1535 (2024).
Schattgen, S. A., Gao, G., Kurt-Jones, E. A. & Fitzgerald, K. A. Cutting edge: DNA in the lung microenvironment during influenza virus infection tempers inflammation by engaging the DNA sensor AIM2. J. Immunol. 196, 29–33 (2016).
Zhang, H. et al. AIM2 inflammasome is critical for influenza-induced lung injury and mortality. J. Immunol. 198, 4383–4393 (2017).
Wang, Y. et al. Influenza virus infection induces ZBP1 expression and necroptosis in mouse lungs. Front. Cell. Infect. Microbiol. 9, 286 (2019).
Kuriakose, T. et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci. Immunol. 1, aag2045 (2016).
Kesavardhana, S. et al. ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death. J. Exp. Med. 214, 2217–2229 (2017).
Le Goffic, R. et al. Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178, 3368–3372 (2007).
Le Goffic, R. et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2, e53 (2006).
Guillot, L. et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280, 5571–5580 (2005).
Xing, Z. et al. Host immune and apoptotic responses to avian influenza virus H9N2 in human tracheobronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 44, 24–33 (2011).
Ioannidis, I. et al. Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J. Virol. 87, 3261–3270 (2013).
Kamiya, Y. et al. Influenza A virus enhances ciliary activity and mucociliary clearance via TLR3 in airway epithelium. Respir. Res. 21, 282 (2020).
Broggi, A. et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 369, 706–712 (2020).
Meng, D. et al. Influenza A viruses replicate productively in mouse mastocytoma cells (P815) and trigger pro-inflammatory cytokine and chemokine production through TLR3 signaling pathway. Front. Microbiol. 7, 2130 (2016).
Rappe, J. C. F. et al. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza. J. Exp. Med. 218, e20201631 (2021).
To, E. E. et al. Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages. Free Radic. Res. 48, 940–947 (2014).
Wang, J. P. et al. Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood 112, 2028–2034 (2008).
Stegemann-Koniszewski, S. et al. Respiratory influenza A virus infection triggers local and systemic natural killer cell activation via toll-like receptor 7. Front. Immunol. 9, 245 (2018).
Pang, I. K., Pillai, P. S. & Iwasaki, A. Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I. Proc. Natl Acad. Sci. Usa. 110, 13910–13915 (2013).
Koupenova, M. et al. The role of platelets in mediating a response to human influenza infection. Nat. Commun. 10, 1780 (2019).
de Marcken, M. et al. TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection. Sci. Signal. 12, eaaw1347 (2019).
Kandasamy, M. et al. RIG-I signaling is critical for efficient polyfunctional T cell responses during influenza virus infection. PLoS Pathog. 12, e1005754 (2016).
Koyama, S. et al. Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J. Immunol. 179, 4711–4720 (2007).
Heer, A. K. et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J. Immunol. 178, 2182–2191 (2007).
Kugler-Umana, O. et al. IgD(+) age-associated B cells are the progenitors of the main T-independent B cell response to infection that generates protective Ab and can be induced by an inactivated vaccine in the aged. Aging Cell 21, e13705 (2022).
Loo, Y. M. et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82, 335–345 (2008).
Molony, R. D. et al. Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes. Sci. Signal. 10, eaan2392 (2017).
Vidaña, B. et al. Involvement of the different lung compartments in the pathogenesis of pH1N1 influenza virus infection in ferrets. Vet. Res. 47, 113 (2016).
Wu, W. et al. RIG-I and TLR3 are both required for maximum interferon induction by influenza virus in human lung alveolar epithelial cells. Virology 482, 181–188 (2015).
Opitz, B. et al. IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell. Microbiol. 9, 930–938 (2007).
Liu, G. et al. Nuclear-resident RIG-I senses viral replication inducing antiviral immunity. Nat. Commun. 9, 3199 (2018).
Zabrodskaya, Y. et al. Exosomes released by influenza-virus-infected cells carry factors capable of suppressing immune defense genes in na‹ve cells. Viruses 14, 2690 (2022).
Zhao, L. et al. Identification of cellular microRNA-136 as a dual regulator of RIG-I-mediated innate immunity that antagonizes H5N1 IAV replication in A549 cells. Sci. Rep. 5, 14991 (2015).
Mäkelä, S. M. et al. RIG-I signaling is essential for influenza B virus-induced rapid interferon gene expression. J. Virol. 89, 12014–12025 (2015).
Wu, W. et al. RIG-I signaling via MAVS is dispensable for survival in lethal influenza infection in vivo. Med. Inflamm. 2018, 6808934 (2018).
Guo, X. et al. Respiratory syncytial virus infection upregulates NLRC5 and major histocompatibility complex class I expression through rig-i induction in airway epithelial cells. J. Virol. 89, 7636–7645 (2015).
Lozhkov, A. A. et al. Simultaneous detection of RIG-1, MDA5, and IFIT-1 expression is a convenient tool for evaluation of the interferon-mediated response. Viruses 14, 2090 (2022).
Goritzka, M. et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J. Exp. Med. 212, 699–714 (2015).
Mohamed, A. A. et al. Influenza A infection stimulates RIG-I and enhances effector function of primary human NK cells. Int. J. Mol. Sci. 24, 12220 (2023).
Zhou, K. et al. Swift and strong NK cell responses protect 129 mice against high-dose influenza virus infection. J. Immunol. 196, 1842–1854 (2016).
Rahim, M. M. A. et al. Defective Influenza A Virus RNA products mediate MAVS-dependent upregulation of human leukocyte antigen class I proteins. J. Virol. 94, e00165–20 (2020).
Ng, K. et al. Responses of human mast cells and epithelial cells following exposure to influenza A virus. Antivir. Res 171, 104566 (2019).
Graham, A. C., Hilmer, K. M., Zickovich, J. M. & Obar, J. J. Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling. J. Immunol. 190, 4676–4684 (2013).
Benitez, A. A. et al. In vivo RNAi screening identifies MDA5 as a significant contributor to the cellular defense against influenza A virus. Cell Rep. 11, 1714–1726 (2015).
LeMessurier, K. S. et al. Influenza A virus directly modulates mouse eosinophil responses. J. Leukoc. Biol. 108, 151–168 (2020).
Chakrabarti, A. et al. RNase L activates the NLRP3 inflammasome during viral infections. Cell Host Microbe 17, 466–477 (2015).
Sabbah, A. et al. Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10, 1073–1080 (2009).
Núñez, R. D. et al. The RNA helicase DDX6 associates with RIG-I to augment induction of antiviral signaling. Int. J. Mol. Sci. 19 (2018).
Hage, A. et al. The RNA helicase DHX16 recognizes specific viral RNA to trigger RIG-I-dependent innate antiviral immunity. Cell Rep. 38, 110434 (2022).
Schulz, O. et al. Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 7, 354–361 (2010).
Jiang, Z. et al. IFI16 directly senses viral RNA and enhances RIG-I transcription and activation to restrict influenza virus infection. Nat. Microbiol. 6, 932–945 (2021).
Thapa, R. J. et al. DAI senses influenza A virus genomic RNA and activates RIPK3-dependent cell death. Cell Host Microbe 20, 674–681 (2016).
Zhang, T. et al. Influenza virus Z-RNAs induce ZBP1-mediated necroptosis. Cell 180, 1115–1129.e1113 (2020).
Kesavardhana, S. et al. The Zα2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development. J. Biol. Chem. 295, 8325–8330 (2020).
Attaway, A. H. et al. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ 372, n436 (2021).
Meyer, N. J., Gattinoni, L. & Calfee, C. S. Acute respiratory distress syndrome. Lancet 398, 622–637 (2021).
Berthelot, J. M. & Lioté, F. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta. EBioMedicine 56, 102801 (2020).
Yang, C. A., Huang, Y. L. & Chiang, B. L. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors. J. Formos. Med. Assoc. 121, 623–632 (2022).
Queiroz, M. A. F. et al. Severe COVID-19 and long COVID are associated with high expression of STING, cGAS and IFN-α. Sci. Rep. 14, 4974 (2024).
Domizio, J. D. et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature 603, 145–151 (2022).
Lebourgeois, S. et al. Differential activation of human neutrophils by SARS-CoV-2 variants of concern. Front. Immunol. 13, 1010140 (2022).
Zhao, X. N. et al. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. Signal Transduct. Target. Ther. 6, 342 (2021).
Heil, M. Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies. Front. Immunol. 14, 1259879 (2023).
Wu, Y. et al. Progress of cGAS-STING signaling in response to SARS-CoV-2 infection. Front. Immunol. 13, 1010911 (2022).
Puray-Chavez, M. et al. A basally active cGAS-STING pathway limits SARS-CoV-2 replication in a subset of ACE2 positive airway cell models. Nat. Commun. 15, 8394 (2024).
Zhou, Z. et al. Sensing of cytoplasmic chromatin by cGAS activates innate immune response in SARS-CoV-2 infection. Signal Transduct. Target. Ther. 6, 382 (2021).
Cai, S. et al. Phase-separated nucleocapsid protein of SARS-CoV-2 suppresses cGAS-DNA recognition by disrupting cGAS-G3BP1 complex. Signal Transduct. Target. Ther. 8, 170 (2023).
Barnett, K. C. et al. An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2. Cell Host Microbe 31, 243–259.e246 (2023).
Ren, H. et al. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection. Biol. Direct 16, 20 (2021).
Liu, X. et al. SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response. Sci. Signal. 15, eabg8744 (2022).
Shaath, H., Vishnubalaji, R., Elkord, E. & Alajez, N. M. Single-cell transcriptome analysis highlights a role for neutrophils and inflammatory macrophages in the pathogenesis of severe COVID-19. Cells 9, 2374 (2020).
Bagheri-Hosseinabadi, Z. et al. mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients. BMC Infect. Dis. 22, 448 (2022).
Chen, L. et al. COVID-19 plasma exosomes promote proinflammatory immune responses in peripheral blood mononuclear cells. Sci. Rep. 12, 21779 (2022).
Li, S. et al. Differentially expressed immune response genes in COVID-19 patients based on disease severity. Aging (Albany N. Y.) 13, 9265–9276 (2021).
Costa, T. J. et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vasc. Pharmacol. 142, 106946 (2022).
Sohn, K. M. et al. COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis. J. Korean Med. Sci. 35, e343 (2020).
Saichi, M. et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat. Cell Biol. 23, 538–551 (2021).
Junqueira, C. et al. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Preprint at https://www.medrxiv.org/content/10.1101/2021.03.06.21252796v1 (2021).
Junqueira, C. et al. FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation. Nature 606, 576–584 (2022).
Colarusso, C. et al. Activation of the AIM2 receptor in circulating cells of post-COVID-19 patients with signs of lung fibrosis is associated with the release of IL-1α, IFN-α and TGF-β. Front. Immunol. 13, 934264 (2022).
Karki, R. et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci. Immunol. 7, eabo6294 (2022).
Yoshimura, J. et al. Classification of patients with COVID-19 by blood RNA endotype: A prospective cohort study. Microbiol. Spectr. 11, e0264523 (2023).
Chomel, L. et al. TLRs1-10 protein expression in circulating human white blood cells during bacterial and COVID-19 infections. J. Innate Immun. 16, 216–225 (2024).
Menezes, M. C. S. et al. Lower peripheral blood toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients. Sci. Rep. 11, 15223 (2021).
Lieberum, J. N. et al. Predictive markers related to local and systemic inflammation in severe COVID-19-associated ARDS: a prospective single-center analysis. BMC Infect. Dis. 23, 19 (2023).
Sorrentino, L. et al. Alterations in the expression of IFN Lambda, IFN gamma and toll-like receptors in severe COVID-19 patients. Microorganisms 11, 689 (2023).
Alturaiki, W. et al. Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severity. Heliyon 9, e12653 (2023).
Naqvi, I. et al. DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists. Biomaterials 283, 121393 (2022).
Zhang, Q., Bastard, P., Cobat, A. & Casanova, J. L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature 603, 587–598 (2022).
Farkas, D. et al. A role for Toll-like receptor 3 in lung vascular remodeling associated with SARS-CoV-2 infection. Preprint at https://www.biorxiv.org/content/10.1101/2023.01.25.524586v1 (2023).
Totura, A. L. et al. Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome Coronavirus infection. mBio 6, e00638–00615 (2015).
Tripathi, U. et al. SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3. Aging (Albany N. Y.) 13, 21838–21854 (2021).
Martínez-Gómez, L. E. et al. Implication of myddosome complex genetic variants in outcome severity of COVID-19 patients. J. Microbiol. Immunol. Infect. 56, 939–950 (2023).
Fallerini, C. et al. Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study. Elife 10 (2021).
Del Carmen Camacho-Rea, M. et al. Association of TLR8 variants in sex-based clinical differences in patients with COVID-19. Biochem. Genet. https://doi.org/10.1007/s10528-024-10839-w (2024).
Wang, C. et al. Deficiency of Tlr7 and Irf7 in mice increases the severity of COVID-19 through the reduced interferon production. Commun. Biol. 7, 1162 (2024).
Fernández, J. J. et al. Innate IRE1α-XBP1 activation by viral single-stranded RNA and its influence on lung cytokine production during SARS-CoV-2 pneumonia. Genes Immun. 25, 43–54 (2024).
Ostapchuk, Y. O. et al. Long-term changes in the phenotype and cytokine production of monocytes in COVID-19 recovered and vaccinated individuals. Infect. Immun. 92, e0021624 (2024).
Wu, D. & Yang, X. O. Dysregulation of pulmonary responses in severe COVID-19. Viruses 13, 957 (2021).
Severa, M. et al. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathog. 17, e1009878 (2021).
Campbell, G. R., To, R. K., Hanna, J. & Spector, S. A. SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway. iScience 24, 102295 (2021).
Gardiman, E. et al. SARS-CoV-2-associated ssRNAs activate human neutrophils in a TLR8-dependent fashion. Cells 11, 3785 (2022).
Liao, T. L. et al. SARS-CoV-2 primed platelets-derived microRNAs enhance NETs formation by extracellular vesicle transmission and TLR7/8 activation. Cell Commun. Signal. 21, 304 (2023).
Lam, Metthew et al. Human red blood cells express the RNA sensor TLR7. Sci. Rep. 14, 15789 (2024).
Salvi, V. et al. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8. JCI Insight 6, e150542 (2021).
van der Sluis, R. M. et al. TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection. EMBO J. 41, e109622 (2022).
Laurent, P. et al. Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19. Sci. Immunol. 7, eadd4906 (2022).
García-Nicolás, O., Godel, A., Zimmer, G. & Summerfield, A. Macrophage phagocytosis of SARS-CoV-2-infected cells mediates potent plasmacytoid dendritic cell activation. Cell. Mol. Immunol. 20, 835–849 (2023).
Nahavandi-Parizi, P., Kariminik, A. & Montazeri, M. Retinoic acid-inducible gene 1 (RIG-1) and IFN-β promoter stimulator-1 (IPS-1) significantly down-regulated in the severe coronavirus disease 2019 (COVID-19). Mol. Biol. Rep. 50, 907–911 (2023).
Hu, Z. et al. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. Elife 11, e77943 (2022).
Vanderboom, P. M. et al. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx. Mol. Cell. Proteom. 20, 100134 (2021).
Pita-Martínez, C. et al. A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia. Int. J. Infect. Dis. 134, 126–132 (2023).
Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 40, 319–324 (2022).
Magalhães, V. G. et al. Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children. EMBO Rep. 24, e57912 (2023).
Tsumita, T. et al. Viral uptake and pathophysiology of the lung endothelial cells in age-associated severe SARS-CoV-2 infection models. Aging Cell 23, e14050 (2024).
Henriques-Pons, A. et al. Pulmonary mesenchymal stem cells in mild cases of COVID-19 are dedicated to proliferation; in severe cases, they control inflammation, make cell dispersion, and tissue regeneration. Front. Immunol. 12, 780900 (2021).
Arai, Y. et al. Stimulation of interferon-β responses by aberrant SARS-CoV-2 small viral RNAs acting as retinoic acid-inducible gene-I agonists. iScience 26, 105742 (2023).
Yamada, T. et al. RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Nat. Immunol. 22, 820–828 (2021).
Si, L. et al. Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activity. Mol. Ther. Nucleic Acids 29, 923–940 (2022).
Thorne, L. G. et al. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. EMBO J. 40, e107826 (2021).
Yang, D. M., Geng, T. T., Harrison, A. G. & Wang, P. H. Differential roles of RIG-I like receptors in SARS-CoV-2 infection. Mil. Med. Res. 8, 49 (2021).
Arefinia, N. et al. Association between expression of ZBP1, AIM2, and MDA5 genes and severity of COVID-19. EXCLI J. 21, 1171–1183 (2022).
Ghoreshi, Z. A. et al. Association between COVID-19 severity and expression of viral nucleic acid sensor genes in peripheral blood mononuclear cells and nasopharyngeal epithelial cells. Am. J. Trop. Med. Hyg. 111, 396–402 (2024).
Bojkova, D. et al. Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection. J. Med. Virol. 95, e28686 (2023).
Yin, X. et al. MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep. 34, 108628 (2021).
Rebendenne, A. et al. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J. Virol. 95, e02415–20 (2021).
Maiti, A. K. MDA5 is a major determinant of developing symptoms in critically Ill COVID-19 patients. Clin. Rev. Allergy Immunol. (2024).
Li, Y. et al. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proc. Natl. Acad. Sci. USA. 118, e2022643118 (2021).
Lee, D. et al. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science 379, eabo3627 (2023).
Kao, K. C. et al. Coinfection and mortality in pneumonia-related acute respiratory distress syndrome patients with bronchoalveolar lavage: A prospective observational study. Shock 47, 615–620 (2017).
Herbst, S. et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol. Med. 7, 240–258 (2015).
Maldonado, S. & Fitzgerald-Bocarsly, P. Antifungal activity of plasmacytoid dendritic cells and the impact of chronic HIV infection. Front. Immunol. 8, 1705 (2017).
Peng, M., Li, X., Zhang, X. & Peng, L. Inhibition of cGAS aggravated the host inflammatory response to Aspergillus fumigatus. Exp. Lung Res. 49, 86–100 (2023).
de Luca, A. et al. Non-hematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell. Mol. Immunol. 7, 459–470 (2010).
Wang, X. et al. MDA5 is an essential sensor of a pathogen-associated molecular pattern associated with vitality that is necessary for host resistance against aspergillus fumigatus. J. Immunol. 205, 3058–3070 (2020).
Steinhagen, F. et al. Immunotherapy in sepsis – brake or accelerate? Pharmacol. Ther. 208, 107476 (2020).
Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 395, 200–211 (2020).
Bode, C. et al. Targeting the host response in sepsis: current approaches and future evidence. Crit. Care 27, 478 (2023).
Lenz, M. et al. Toll-like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients. Shock 54, 35–43 (2020).
Silva, S. C. et al. Evaluation of toll-like, chemokine, and integrin receptors on monocytes and neutrophils from peripheral blood of septic patients and their correlation with clinical outcomes. Braz. J. Med. Biol. Res. 47, 384–393 (2014).
Atalan, N. et al. The relationship between sepsis-induced immunosuppression and serum toll-like receptor 9 level. Vivo 32, 1653–1658 (2018).
Trevelin, S. C. et al. Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome. Crit. Care Med. 40, 2631–2637 (2012).
Xu, L. et al. TLR9 signaling in fibroblastic reticular cells regulates peritoneal immunity. J. Clin. Invest. 129, 3657–3669 (2019).
Nanushaj, D. et al. Nucleic acid sensing toll-like receptors 3 and 9 play complementary roles in the development of bacteremia after nasal colonization associated with influenza co-infection. Exp. Anim. 73, 50–60 (2024).
Krieg, A. M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709–760 (2002).
Kumar, V. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int. Immunopharmacol. 89, 107087 (2020).
Tsujimoto, H. et al. A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells. J. Hepatol. 45, 836–843 (2006).
Cornélie, S. et al. Cytosine-phosphate-guanine (CpG) motifs are sensitizing agents for lipopolysaccharide in toxic shock model. Intensive Care Med. 28, 1340–1347 (2002).
Rice, L. et al. CpG oligodeoxynucleotide protection in polymicrobial sepsis is dependent on interleukin-17. J. Infect. Dis. 191, 1368–1376 (2005).
Biondo, C. et al. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. Eur. J. Immunol. 41, 1969–1979 (2011).
Nakamura, K. et al. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J. Immunol. 180, 4067–4074 (2008).
da Silva-Junior, E. B. et al. The role of Toll-like receptor 9 in a murine model of Cryptococcus gattii infection. Sci. Rep. 11, 1407 (2021).
Wahyuningsih, R., Freisleben, H. J., Sonntag, H. G. & Schnitzler, P. Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis. J. Clin. Microbiol. 38, 3016–3021 (2000).
Visitchanakun, P. et al. Interference on cytosolic DNA activation attenuates sepsis severity: Experiments on cyclic GMP-AMP synthase (cGAS) deficient mice. Int. J. Mol. Sci. 22, 11450 (2021).
Erttmann, S. F. et al. The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. Immunity 55, 847–861.e810 (2022).
Huang, L. S. et al. mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury. Immunity 52, 475–486.e475 (2020).
Su, J. et al. Sensing cytosolic DNA lowers blood pressure by direct cGAMP-dependent PKGI activation. Circulation 148, 1023–1034 (2023).
Zhang, X. et al. RIPK3-MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis. Clin. Transl. Med. 13, e1334 (2023).
Yang, M. et al. STING activation in platelets aggravates septic thrombosis by enhancing platelet activation and granule secretion. Immunity 56, 1013–1026.e1016 (2023).
Gould, T. J. et al. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler. Thromb. Vasc. Biol. 34, 1977–1984 (2014).
Iba, T. & Levy, J. H. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Anesthesiology 132, 1238–1245 (2020).
McDonald, B. et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice. Blood 129, 1357–1367 (2017).
Allen, E. R. et al. Extracellular vesicles from A23187-treated neutrophils cause cGAS-STING-dependent IL-6 production by macrophages. Front. Immunol. 13, 949451 (2022).
Bhagirath, V. C., Dwivedi, D. J. & Liaw, P. C. Comparison of the proinflammatory and procoagulant properties of nuclear, mitochondrial, and bacterial DNA. Shock 44, 265–271 (2015).
Tu, Q. et al. Mitochondrial DNA mediates immunoparalysis of dendritic cells in sepsis via STING signalling. Cell Prolif. 55, e13328 (2022).
Luan, Y. Y. et al. STING modulates necrotic cell death in CD4 T cells via activation of PARP-1/PAR following acute systemic inflammation. Int. Immunopharmacol. 109, 108809 (2022).
Long, J. et al. Notch signaling protects CD4 T cells from STING-mediated apoptosis during acute systemic inflammation. Sci. Adv. 6, eabc5447 (2020).
Busani, S. et al. Increased plasma levels of mitochondrial DNA and normal inflammasome gene expression in monocytes characterize patients with septic shock due to multidrug resistant bacteria. Front. Immunol. 11, 768 (2020).
Yang, J., Liu, W., Xu, M. & Yu, L. Long non-coding RNA CRNDE and toll-like receptor 3 correlate with disease severity, inflammation, and mortality in sepsis. J. Clin. Lab. Anal. 34, e23360 (2020).
Ding, X. et al. TLR4 signaling induces TLR3 up-regulation in alveolar macrophages during acute lung injury. Sci. Rep. 7, 34278 (2017).
Koerner, P. et al. Stimulation of TLR7 prior to polymicrobial sepsis improves the immune control of the inflammatory response in adult mice. Inflamm. Res. 60, 271–279 (2011).
Xu, J. et al. Circulating plasma extracellular vesicles from septic mice induce inflammation via MicroRNA- and TLR7-dependent mechanisms. J. Immunol. 201, 3392–3400 (2018).
Jian, W. et al. Toll-like receptor 7 contributes to inflammation, organ injury, and mortality in murine sepsis. Anesthesiology 131, 105–118 (2019).
Williams, B. et al. Toll-like receptors 2 and 7 mediate coagulation activation and coagulopathy in murine sepsis. J. Thromb. Haemost. 17, 1683–1693 (2019).
Williams, B., Zhu, J., Zou, L. & Chao, W. Innate immune TLR7 signaling mediates platelet activation and platelet-leukocyte aggregate formation in murine bacterial sepsis. Platelets 33, 1251–1259 (2022).
Xie, K. et al. Bioinformatics-based study to investigate potential differentially expressed genes and miRNAs in pediatric sepsis. Med. Sci. Monit. 26, e923881 (2020).
Niu, J. et al. Identification of key immune-related genes in the progression of septic shock. Front. Genet. 12, 668527 (2021).
Dawulieti, J. et al. Treatment of severe sepsis with nanoparticulate cell-free DNA scavengers. Sci. Adv. 6, eaay7148 (2020).
Wu, J. et al. The interaction between STING and NCOA4 exacerbates lethal sepsis by orchestrating ferroptosis and inflammatory responses in macrophages. Cell Death Dis. 13, 653 (2022).
Huang, W. et al. Self-propelled proteomotors with active cell-free mtDNA clearance for enhanced therapy of sepsis-associated acute lung injury. Adv. Sci. (Weinh.) 10, e2301635 (2023).
Zeng, Z. et al. Mitochondrial DNA plays an important role in lung injury induced by sepsis. J. Cell. Biochem. 120, 8547–8560 (2019).
Zhang, L. et al. Intra-peritoneal administration of mitochondrial DNA provokes acute lung injury and systemic inflammation via toll-like receptor 9. Int. J. Mol. Sci. 17, 1425 (2016).
Wu, G. et al. Extracellular mitochondrial DNA promote NLRP3 inflammasome activation and induce acute lung injury through TLR9 and NF-κB. J. Thorac. Dis. 11, 4816–4828 (2019).
Chen, X., Wang, T., Song, L. & Liu, X. Activation of multiple Toll-like receptors serves different roles in sepsis-induced acute lung injury. Exp. Ther. Med. 18, 443–450 (2019).
Du, X. K., Ge, W. Y., Jing, R. & Pan, L. H. Necroptosis in pulmonary macrophages mediates lipopolysaccharide-induced lung inflammatory injury by activating ZBP-1. Int. Immunopharmacol. 77, 105944 (2019).
Gong, T. et al. Decoding the multiple functions of ZBP1 in the mechanism of sepsis-induced acute lung injury. Commun. Biol. 7, 1361 (2024).
Liu, Q. et al. Circulating mitochondrial DNA-triggered autophagy dysfunction via STING underlies sepsis-related acute lung injury. Cell Death Dis. 12, 673 (2021).
Ning, L. et al. Cytosolic DNA-STING-NLRP3 axis is involved in murine acute lung injury induced by lipopolysaccharide. Clin. Transl. Med. 10, e228 (2020).
Wang, J. et al. HMGB1 participates in LPS‑induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF‑κB signaling pathways. Int. J. Mol. Med. 45, 61–80 (2020).
Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134–147 (2018).
Gu, J. et al. Glycyrrhizin alleviates sepsis-induced acute respiratory distress syndrome via suppressing of HMGB1/TLR9 pathways and neutrophils extracellular traps formation. Int. Immunopharmacol. 108, 108730 (2022).
Zhu, S. et al. Neutrophil extracellular traps contribute to immunothrombosis formation via the STING pathway in sepsis-associated lung injury. Cell Death Discov. 9, 315 (2023).
Zhao, J. et al. NETs promote inflammatory injury by activating cGAS-STING pathway in acute lung injury. Int. J. Mol. Sci. 24, 5125 (2023).
Pedrazza, L. et al. Mesenchymal stem cells cannot affect mRNA expression of toll-like receptors in different tissues during sepsis. Inflamm. Res. 66, 547–551 (2017).
Huang, H. et al. TLR7 mediates acute respiratory distress syndrome in sepsis by sensing extracellular miR-146a. Am. J. Respir. Cell Mol. Biol. 67, 375–388 (2022).
Wang, A., Kang, X., Wang, J. & Zhang, S. IFIH1/IRF1/STAT1 promotes sepsis associated inflammatory lung injury via activating macrophage M1 polarization. Int. Immunopharmacol. 114, 109478 (2023).
Li, J., Lu, Y. & Lin, G. Blocking cGAS/STING signaling protects against sepsis-associated acute liver injury. Int. Immunopharmacol. 113, 109276 (2022).
Zhang, Q. et al. STING signaling sensing of DRP1-dependent mtDNA release in kupffer cells contributes to lipopolysaccharide-induced liver injury in mice. Redox Biol. 54, 102367 (2022).
Carchman, E. H. et al. Experimental sepsis-induced mitochondrial biogenesis is dependent on autophagy, TLR4, and TLR9 signaling in liver. FASEB J. 27, 4703–4711 (2013).
Schuchmann, M. et al. HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells. Immunol. Lett. 93, 199–204 (2004).
Slotta, J. E., Scheuer, C., Menger, M. D. & Vollmar, B. Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damage. J. Hepatol. 44, 576–585 (2006).
Zhou, R. et al. A new cell death program regulated by toll-like receptor 9 through p38 mitogen-activated protein kinase signaling pathway in a neonatal rat model with sepsis associated encephalopathy. Chin. Med. J. (Engl.) 135, 1474–1485 (2022).
Xiaofeng, G. et al. PERK-STING-RIPK3 pathway facilitates cognitive impairment by inducing neuronal necroptosis in sepsis-associated encephalopathy. CNS Neurosci. Ther. 29, 1178–1191 (2023).
Zou, L. et al. Brain innate immune response via miRNA-TLR7 sensing in polymicrobial sepsis. Brain. Behav. Immun. 100, 10–24 (2022).
Park, C. et al. Extracellular vesicles in sepsis plasma mediate neuronal inflammation in the brain through miRNAs and innate immune signaling. J. Neuroinflamm. 21, 252 (2024).
Li, N. et al. STING-IRF3 contributes to lipopolysaccharide-induced cardiac dysfunction, inflammation, apoptosis and pyroptosis by activating NLRP3. Redox Biol. 24, 101215 (2019).
Knuefermann, P. et al. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9. Cardiovasc. Res. 78, 26–35 (2008).
Gao, M. et al. The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling. J. Infect. Dis. 207, 1471–1479 (2013).
Fattahi, F. et al. Harmful roles of TLR3 and TLR9 in cardiac dysfunction developing during polymicrobial sepsis. Biomed. Res. Int. 2018, 4302726 (2018).
Gao, M. et al. Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Crit. Care Med. 40, 2390–2399 (2012).
Saiyang, X. et al. Activation of toll-like receptor 7 provides cardioprotection in septic cardiomyopathy-induced systolic dysfunction. Clin. Transl. Med. 11, e266 (2021).
Tsuji, N. et al. Role of mitochondrial DNA in septic AKI via toll-like receptor 9. J. Am. Soc. Nephrol. 27, 2009–2020 (2016).
Naito, Y. et al. IL-17A activated by Toll-like receptor 9 contributes to the development of septic acute kidney injury. Am. J. Physiol. Ren. Physiol. 318, F238–F247 (2020).
Luo, X. et al. Cytosolic mtDNA-cGAS-STING axis contributes to sepsis-induced acute kidney injury via activating the NLRP3 inflammasome. Clin. Exp. Nephrol. 28, 375–390 (2024).
Dong, Y. et al. Non-canonical STING-PERK pathway modulation of cellular senescence and therapeutic response in sepsis-associated acute kidney injury. Inflammation. https://doi.org/10.1007/s10753-024-02081-8 (2024).
Sun, S. et al. Neutrophil extracellular traps impair intestinal barrier functions in sepsis by regulating TLR9-mediated endoplasmic reticulum stress pathway. Cell Death Dis. 12, 606 (2021).
Hu, Q. et al. STING-mediated intestinal barrier dysfunction contributes to lethal sepsis. EBioMedicine 41, 497–508 (2019).
Balogh, Z. J. Polytrauma: It is a disease. Injury 53, 1727–1729 (2022).
Hardy, B. M. et al. The outcomes of the most severe polytrauma patients: a systematic review of the use of high ISS cutoffs for performance measurement. Eur. J. Trauma Emerg. Surg. 50, 1305–1312 (2024).
Thurairajah, K., Briggs, G. D. & Balogh, Z. J. The source of cell-free mitochondrial DNA in trauma and potential therapeutic strategies. Eur. J. Trauma Emerg. Surg. 44, 325–334 (2018).
Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104–107 (2010).
McIlroy, D. J. et al. Cell necrosis-independent sustained mitochondrial and nuclear DNA release following trauma surgery. J. Trauma Acute Care Surg. 78, 282–288 (2015).
Naumann, D. N. et al. Endotheliopathy is associated with higher levels of cell-free DNA following major trauma: A prospective observational study. PLoS One 12, e0189870 (2017).
Trulson, I. et al. Cell-free DNA in plasma and serum indicates disease severity and prognosis in blunt trauma patients. Diagnostics (Basel) 13, 1150 (2023).
Regner, A. et al. Prognostic utility of circulating nucleic acids in acute brain injuries. Expert Rev. Mol. Diagn. 18, 925–938 (2018).
Ren, B. et al. Is plasma cell-free DNA really a useful marker for diagnosis and treatment of trauma patients? Clin. Chim. Acta 424, 109–113 (2013).
Chornenki, Jackson et al. Comparison of the source and prognostic utility of cfDNA in trauma and sepsis. Intensive Care Med. Exp. 7, 29 (2019).
Marcatti, M. et al. Quantification of circulating cell free mitochondrial DNA in extracellular vesicles with PicoGreen™ in liquid biopsies: Fast assessment of disease/trauma severity. Cells 10, 819 (2021).
Popescu, N. I., Lupu, C. & Lupu, F. Disseminated intravascular coagulation and its immune mechanisms. Blood 139, 1973–1986 (2022).
Liaw, P. C. et al. DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. Blood Rev. 30, 257–261 (2016).
Sawamura, A. et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb. Res. 124, 608–613 (2009).
Swystun, L. L., Mukherjee, S. & Liaw, P. C. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J. Thromb. Haemost. 9, 2313–2321 (2011).
Oehmcke, S., Mörgelin, M. & Herwald, H. Activation of the human contact system on neutrophil extracellular traps. J. Innate Immun. 1, 225–230 (2009).
Gansler, J. et al. Structural requirements for the procoagulant activity of nucleic acids. PLoS One 7, e50399 (2012).
Goswami, J. et al. DNAse mediated dissolution of neutrophil extracellular traps (NETs) accelerates in vitro thrombin generation kinetics in trauma patients. Shock 58, 217–223 (2022).
Longstaff, C. et al. Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones. J. Biol. Chem. 288, 6946–6956 (2013).
Komissarov, A. A., Florova, G. & Idell, S. Effects of extracellular DNA on plasminogen activation and fibrinolysis. J. Biol. Chem. 286, 41949–41962 (2011).
Gould, T. J., Lysov, Z. & Liaw, P. C. Extracellular DNA and histones: double-edged swords in immunothrombosis. J. Thromb. Haemost. 13, S82–S91 (2015).
Faust, H. E. et al. Plasma mitochondrial DNA levels are associated with ARDS in trauma and sepsis patients. Chest 157, 67–76 (2020).
Comish, P. B. et al. The cGAS-STING pathway connects mitochondrial damage to inflammation in burn-induced acute lung injury in rat. Burns 48, 168–175 (2022).
Roth, S. et al. Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade. Immunity 54, 648–659.e648 (2021).
Lee, S. W. et al. The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury. J. Neuroinflamm. 16, 27 (2019).
Yuan, B. et al. Inhibition of AIM2 inflammasome activation alleviates GSDMD-induced pyroptosis in early brain injury after subarachnoid haemorrhage. Cell Death Dis. 11, 76 (2020).
Stanojcic, M. et al. Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury. Crit. Care Med. 42, 1357–1364 (2014).
Osuka, A., Hanschen, M., Stoecklein, V. & Lederer, J. A. A protective role for inflammasome activation following injury. Shock 37, 47–55 (2012).
Wu, Y. et al. MitoQ protects against liver injury induced by severe burn plus delayed resuscitation by suppressing the mtDNA-NLRP3 axis. Int. Immunopharmacol. 80, 106189 (2020).
Suen, A. O. et al. Extracellular RNA sensing mediates inflammation and organ injury in a murine model of polytrauma. J. Immunol. 210, 1990–2000 (2023).
Suresh, M. V. et al. Double-stranded RNA interacts with toll-like receptor 3 in driving the acute inflammatory response following lung contusion. Crit. Care Med. 44, e1054–e1066 (2016).
Williams, B., Kozar, R. & Chao, W. Emerging role of extracellular RNA in innate immunity, sepsis, and trauma. Shock 59, 190–199 (2023).
Soares, R. O. S. et al. Ischemia/reperfusion injury revisited: An overview of the latest pharmacological strategies. Int. J. Mol. Sci. 20, 5034 (2019).
Hu, Q. et al. The role of mitochondrial DNA in the development of ischemia reperfusion injury. Shock 51, 52–59 (2019).
Khan, M. A. et al. Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus 12, e9349 (2020).
Roué, M. et al. In-hospital outcomes after acute myocardial infarction with obstructive coronary artery disease in critically ill patients hospitalized for non-cardiac disease. Ann. Intensive Care 13, 87 (2023).
Liu, F. Y. et al. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis. 10, 480 (2019).
Becher, P. M. et al. Role of toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor. PLoS One 13, e0193844 (2018).
Tian, Y. et al. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway. J. Thorac. Cardiovasc. Surg. 157, 2256–2269.e2253 (2019).
Kitazume-Taneike, R. et al. Ablation of Toll-like receptor 9 attenuates myocardial ischemia/reperfusion injury in mice. Biochem. Biophys. Res. Commun. 515, 442–447 (2019).
Xie, L. et al. Exogenous administration of mitochondrial DNA promotes ischemia reperfusion injury via TLR9-p38 MAPK pathway. Regul. Toxicol. Pharmacol. 89, 148–154 (2017).
Bliksøen, M. et al. Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes. Basic Res. Cardiol. 111, 42 (2016).
Xie, D. et al. Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashion. Basic Res. Cardiol. 118, 44 (2023).
Omiya, S. et al. Toll-like receptor 9 prevents cardiac rupture after myocardial infarction in mice independently of inflammation. Am. J. Physiol. Heart Circ. Physiol. 311, H1485–H1497 (2016).
Cao, D. J. et al. Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury. Circulation 137, 2613–2634 (2018).
Lai, L. et al. Plasmacytoid dendritic cells mediate myocardial ischemia/reperfusion injury by secreting type I interferons. J. Am. Heart Assoc. 10, e020754 (2021).
Zhang, W. et al. Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase. Cardiovasc. Res. https://doi.org/10.1093/cvr/cvae218 (2024).
Xiong, Y. et al. Decreased MFN2 activates the cGAS-STING pathway in diabetic myocardial ischaemia-reperfusion by triggering the release of mitochondrial DNA. Cell Commun. Signal. 21, 192 (2023).
Zhang, C. et al. Intercellular mitochondrial component transfer triggers ischemic cardiac fibrosis. Sci. Bull. (Beijing) 68, 1784–1799 (2023).
Durga Devi, T. et al. Aggravated postinfarct heart failure in type 2 diabetes is associated with impaired mitophagy and exaggerated inflammasome activation. Am. J. Pathol. 187, 2659–2673 (2017).
Zhao, Y. et al. AIM2 inflammasome regulated by the IFN-γ/JAK2/STAT1 pathway promotes activation and pyroptosis of monocytes in Coronary Artery Disease. Immun. Inflamm. Dis. 12, e1317 (2024).
Pomerantz, B. J., Reznikov, L. L., Harken, A. H. & Dinarello, C. A. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc. Natl Acad. Sci. Usa. 98, 2871–2876 (2001).
Deng, Y. et al. IFI-16 inhibition attenuates myocardial remodeling following myocardial infarction. iScience 27, 110568 (2024).
Enzan, N. et al. ZBP1 protects against mtDNA-induced myocardial inflammation in failing hearts. Circ. Res. 132, 1110–1126 (2023).
Rotter Sopasakis, V. et al. Toll-like receptor-mediated inflammation markers are strongly induced in heart tissue in patients with cardiac disease under both ischemic and non-ischemic conditions. Int. J. Cardiol. 293, 238–247 (2019).
Chen, C. et al. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury. J. Am. Heart Assoc. 3, e000683 (2014).
Wang, X. et al. TLR3 mediates repair and regeneration of damaged neonatal heart through glycolysis dependent YAP1 regulated miR-152 expression. Cell Death Differ. 25, 966–982 (2018).
Gao, T. et al. TLR3 contributes to persistent autophagy and heart failure in mice after myocardial infarction. J. Cell. Mol. Med. 22, 395–408 (2018).
Gollmann-Tepeköylü, C. et al. Toll-like receptor 3 mediates ischaemia/reperfusion injury after cardiac transplantation. Eur. J. Cardiothorac. Surg. 57, 826–835 (2020).
Li, X., Guo, D., Chen, Y. & Hu, Y. Toll-like receptors/TNF-α pathway crosstalk and impact on different sites of recurrent myocardial infarction in elderly patients. Biomed. Res. Int. 2022, 1280350 (2022).
de Kleijn, D. P. V. et al. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction. Cardiovasc. Res. 115, 1791–1803 (2019).
Qian, J. et al. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute myocardial infarction. Front. Immunol. 13, 908815 (2022).
Feng, Y. et al. Cardiac RNA induces inflammatory responses in cardiomyocytes and immune cells via toll-like receptor 7 signaling. J. Biol. Chem. 290, 26688–26698 (2015).
Liu, Z. et al. Increased sympathetic outflow induced by emotional stress aggravates myocardial ischemia-reperfusion injury via activation of TLR7/MyD88/IRF5 signaling pathway. Inflamm. Res. 72, 901–913 (2023).
Mao, X. L. et al. Novel targets and therapeutic strategies to protect against hepatic ischemia reperfusion injury. Front. Med. (Lausanne) 8, 757336 (2021).
Bamboat, Z. M. et al. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51, 621–632 (2010).
Kim, H. Y., Kim, S. J. & Lee, S. M. Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion. FEBS J. 282, 259–270 (2015).
Xiong, Y. et al. Blockade of the mitochondrial DNA release ameliorates hepatic ischemia-reperfusion injury through avoiding the activation of cGAS-Sting pathway. J. Transl. Med. 22, 796 (2024).
Jiao, J. et al. Expression of STING is increased in monocyte-derived macrophages and contributes to liver inflammation in hepatic ischemia-reperfusion injury. Am. J. Pathol. 192, 1745–1762 (2022).
Wu, D. et al. tBHQ mitigates fatty liver ischemia-reperfusion injury by activating Nrf2 to attenuate hepatocyte mitochondrial damage and macrophage STING activation. Int. Immunopharmacol. 138, 112515 (2024).
Zhong, W. et al. Aging aggravated liver ischemia and reperfusion injury by promoting STING-mediated NLRP3 activation in macrophages. Aging Cell 19, e13186 (2020).
Lei, Z. et al. cGAS-mediated autophagy protects the liver from ischemia-reperfusion injury independently of STING. Am. J. Physiol. Gastrointest. Liver Physiol. 314, G655–G667 (2018).
Malek, M. & Nematbakhsh, M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J. Ren. Inj. Prev. 4, 20–27 (2015).
Han, S. J. et al. Intestinal toll-like receptor 9 deficiency leads to Paneth cell hyperplasia and exacerbates kidney, intestine, and liver injury after ischemia/reperfusion injury. Kidney Int 95, 859–879 (2019).
Han, S. J. et al. Kidney proximal tubular TLR9 exacerbates ischemic acute kidney injury. J. Immunol. 201, 1073–1085 (2018).
Feng, Y. et al. RIP3 translocation into mitochondria promotes mitofilin degradation to increase inflammation and kidney injury after renal ischemia-reperfusion. Cells 11, 1894 (2022).
Song, Z. et al. Inhibition of Drp1- Fis1 interaction alleviates aberrant mitochondrial fragmentation and acute kidney injury. Cell. Mol. Biol. Lett. 29, 31 (2024).
Li, J. et al. Phosphoglycerate mutase 5 initiates inflammation in acute kidney injury by triggering mitochondrial DNA release by dephosphorylating the pro-apoptotic protein Bax. Kidney Int 103, 115–133 (2023).
Jiang, A., Liu, J., Wang, Y. & Zhang, C. cGAS-STING signaling pathway promotes hypoxia-induced renal fibrosis by regulating PFKFB3-mediated glycolysis. Free Radic. Biol. Med. 208, 516–529 (2023).
Jin, L. et al. STING promotes ferroptosis through NCOA4-dependent ferritinophagy in acute kidney injury. Free Radic. Biol. Med. 208, 348–360 (2023).
Yang, H. et al. Roxadustat (FG-4592) protects against ischaemia-induced acute kidney injury via improving CD73 and decreasing AIM2 inflammasome activation. Nephrol. Dial. Transplant. 38, 858–875 (2023).
Paulus, P. et al. The early activation of toll-like receptor (TLR)-3 initiates kidney injury after ischemia and reperfusion. PLoS One 9, e94366 (2014).
Tang, R. et al. Single-cell RNA sequencing reveals the transcriptomic landscape of kidneys in patients with ischemic acute kidney injury. Chin. Med. J. (Engl.) 136, 1177–1187 (2023).
Demaria, O. et al. Harnessing innate immunity in cancer therapy. Nature 574, 45–56 (2019).
Schumann, T. et al. Deficiency for SAMHD1 activates MDA5 in a cGAS/STING-dependent manner. J. Exp. Med. 220, e20220829 (2023).
Dressel, N. et al. Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis. Cancer Res 83, 2858–2872 (2023).
Hu, S. et al. cGAS restricts colon cancer development by protecting intestinal barrier integrity. Proc. Natl. Acad. Sci. USA 118, e2105747118 (2021).
Zhu, H. et al. RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer. J. Exp. Clin. Cancer Res. 36, 2 (2017).
Song, J. et al. Mutant RIG-I enhances cancer-related inflammation through activation of circRIG-I signaling. Nat. Commun. 13, 7096 (2022).
Zhang, W. et al. The mitochondrial protein MAVS stabilizes p53 to suppress tumorigenesis. Cell Rep. 30, 725–738.e724 (2020).
Katlinski, K. V. et al. Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment. Cancer Cell 31, 194–207 (2017).
Bu, Y., Liu, F., Jia, Q. A. & Yu, S. N. Decreased expression of TMEM173 predicts poor prognosis in patients with hepatocellular carcinoma. PLoS One 11, e0165681 (2016).
Song, S. et al. Decreased expression of STING predicts poor prognosis in patients with gastric cancer. Sci. Rep. 7, 39858 (2017).
Lubbers, J. M. et al. Association of homozygous variants of STING1 with outcome in human cervical cancer. Cancer Sci. 112, 61–71 (2021).
Li, T. & Chen, Z. J. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J. Exp. Med. 215, 1287–1299 (2018).
Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467–472 (2018).
Msaouel, P. et al. Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma. Cancer Cell 37, 720–734.e713 (2020).
Man, S. M. & Jenkins, B. J. Context-dependent functions of pattern recognition receptors in cancer. Nat. Rev. Cancer 22, 397–413 (2022).
Christensen, S. R. et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202, 321–331 (2005).
Pisitkun, P. et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669–1672 (2006).
Souyris, M. et al. TLR7 escapes X chromosome inactivation in immune cells. Sci. Immunol. 3, eaap8855 (2018).
Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349–356 (2022).
Al-Azab, M. et al. Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus. Nat. Immunol. 25, 969–980 (2024).
David, C. et al. Gain-of-function human UNC93B1 variants cause systemic lupus erythematosus and chilblain lupus. J. Exp. Med. 221, e20232066 (2024).
Rael, V. E. et al. Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans. J. Exp. Med. 221, e20232005 (2024).
Wolf, C. et al. UNC93B1 variants underlie TLR7-dependent autoimmunity. Sci. Immunol. 9, eadi9769 (2024).
Mishra, H. et al. Disrupted degradative sorting of TLR7 is associated with human lupus. Sci. Immunol. 9, eadi9575 (2024).
Crow, Y. J. & Stetson, D. B. The type I interferonopathies: 10 years on. Nat. Rev. Immunol. 22, 471–483 (2022).
Aguado, J. et al. Inhibition of the cGAS-STING pathway ameliorates the premature senescence hallmarks of Ataxia-Telangiectasia brain organoids. Aging Cell 20, e13468 (2021).
Gratia, M. et al. Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS. J. Exp. Med. 216, 1199–1213 (2019).
Liu, Y. et al. Activated STING in a vascular and pulmonary syndrome. N. Engl. J. Med. 371, 507–518 (2014).
Zhang, X., Bai, X. C. & Chen, Z. J. Structures and mechanisms in the cGAS-STING innate immunity pathway. Immunity 53, 43–53 (2020).
Warner, J. D. et al. STING-associated vasculopathy develops independently of IRF3 in mice. J. Exp. Med. 214, 3279–3292 (2017).
Luksch, H. et al. STING-associated lung disease in mice relies on T cells but not type I interferon. J. Allergy Clin. Immunol. 144, 254–266.e258 (2019).
Jeltema, D., Abbott, K. & Yan, N. STING trafficking as a new dimension of immune signaling. J. Exp. Med. 220, e20220990 (2023).
Lepelley, A. et al. Mutations in COPA lead to abnormal trafficking of STING to the Golgi and interferon signaling. J. Exp. Med. 217, e20200600 (2020).
Mukai, K. et al. Homeostatic regulation of STING by retrograde membrane traffic to the ER. Nat. Commun. 12, 61 (2021).
Chu, T. T. et al. Tonic prime-boost of STING signalling mediates Niemann-Pick disease type C. Nature 596, 570–575 (2021).
Funabiki, M. et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 40, 199–212 (2014).
Rice, G. I. et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat. Genet. 46, 503–509 (2014).
Mannion, N. M. et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 9, 1482–1494 (2014).
Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548–569 (2021).
Luca, D. et al. Aberrant RNA sensing in regulatory T cells causes systemic autoimmunity. Sci. Adv. 10, eadk0820 (2024).
Silva, J. A. et al. Association of interferon-induced helicase C domain (IFIH1) gene polymorphisms with systemic lupus erythematosus and a relevant updated meta-analysis. Genet. Mol. Res. 15, gmr15048008 (2016).
Zhang, J. et al. Autoimmune disease associated IFIH1 single nucleotide polymorphism related with IL-18 serum levels in Chinese systemic lupus erythematosus patients. Sci. Rep. 8, 9442 (2018).
Jang, M. A. et al. Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am. J. Hum. Genet. 96, 266–274 (2015).
Buers, I., Nitschke, Y. & Rutsch, F. Novel interferonopathies associated with mutations in RIG-I like receptors. Cytokine Growth Factor Rev. 29, 101–107 (2016).
Xu, Q. et al. The role of the cGAS-STING pathway in metabolic diseases. Heliyon 10, e33093 (2024).
Nishimoto, S. et al. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Sci. Adv. 2, e1501332 (2016).
Weisberg, S. P. et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115–124 (2006).
Miura, K. et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139, 323–334.e327 (2010).
Kayserova, J. et al. Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients. Clin. Immunol. 153, 49–55 (2014).
Sha, S. et al. TLR9 deficiency in B cells promotes immune tolerance via interleukin-10 in a type 1 diabetes mouse model. Diabetes 70, 504–515 (2021).
Yu, Y. et al. STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis. J. Clin. Invest. 129, 546–555 (2019).
Bai, J. et al. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. Proc. Natl Acad. Sci. Usa. 114, 12196–12201 (2017).
Petrasek, J. et al. STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proc. Natl Acad. Sci. USA 110, 16544–16549 (2013).
Mao, Y. et al. STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity. Arterioscler. Thromb. Vasc. Biol. 37, 920–929 (2017).
Gao, H. et al. Accumulation of microbial DNAs promotes to islet inflammation and β cell abnormalities in obesity in mice. Nat. Commun. 13, 565 (2022).
Qiao, J. et al. A distinct role of STING in regulating glucose homeostasis through insulin sensitivity and insulin secretion. Proc. Natl. Acad. Sci. USA. 119, e2101848119 (2022).
Wu, D. et al. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity 44, 1325–1336 (2016).
Field, C. S. et al. Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function. Cell Metab. 31, 422–437.e425 (2020).
Walford, R. L. The immunologic theory of aging. Gerontologist 4, 195–197 (1964).
Yang, H. et al. cGAS is essential for cellular senescence. Proc. Natl Acad. Sci. USA 114, E4612–e4620 (2017).
Glück, S. et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat. Cell Biol. 19, 1061–1070 (2017).
Simon, M. et al. LINE1 derepression in aged wild-type and SIRT6-deficient mice drives inflammation. Cell Metab. 29, 871–885.e875 (2019).
De Cecco, M. et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 566, 73–78 (2019).
Kerur, N. et al. cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat. Med. 24, 50–61 (2018).
Gulen, M. F. et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374–380 (2023).
López-Polo, V. et al. Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells. Nat. Commun. 15, 7378 (2024).
Sladitschek-Martens, H. L. et al. YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS-STING. Nature 607, 790–798 (2022).
Kreienkamp, R. et al. A cell-intrinsic interferon-like response links replication stress to cellular aging caused by progerin. Cell Rep. 22, 2006–2015 (2018).
Puente, X. S. et al. Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am. J. Hum. Genet. 88, 650–656 (2011).
Cabanillas, R. et al. Néstor-Guillermo progeria syndrome: A novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am. J. Med. Genet. A 155a, 2617–2625 (2011).
Guey, B. et al. BAF restricts cGAS on nuclear DNA to prevent innate immune activation. Science 369, 823–828 (2020).
Hao, Y. et al. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 118, 1294–1304 (2011).
Rubtsov, A. V. et al. Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood 118, 1305–1315 (2011).
Aramburu, I. V. et al. Functional proteomic profiling links deficient DNA clearance with increased mortality in individuals with severe COVID-19 pneumonia. Immunity 55, 2436–2453.e2435 (2022).
Garcia, G. et al. Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease. J. Transl. Med. 22, 246 (2024).
Garcinuño, S. et al. Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis. Front. Immunol. 15, 1443096 (2024).
Lefrançais, E. et al. Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury. JCI Insight 3, e98178 (2018).
Jiménez-Alcázar, M. et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science 358, 1202–1206 (2017).
Meng, W. et al. Deoxyribonuclease is a potential counter regulator of aberrant neutrophil extracellular traps formation after major trauma. Med. Inflamm. 2012, 149560 (2012).
Kuribara, J. et al. Levels of serum deoxyribonuclease I activity on admission in patients with acute myocardial infarction can be useful in predicting left ventricular enlargement due to remodeling. J. Cardiol. 53, 196–203 (2009).
Jarrahi, A. et al. Recombinant human DNase-I improves acute respiratory distress syndrome via neutrophil extracellular trap degradation. J. Thromb. Haemost. 21, 2473–2484 (2023).
Zhang, H. et al. METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury. Clin. Transl. Med. 13, e1389 (2023).
Kwak, S. B. et al. Development of a rectally administrable Dnase1 to treat septic shock by targeting NETs. Life Sci. 342, 122526 (2024).
Ge, L. et al. Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy. Am. J. Physiol. Heart Circ. Physiol. 308, H500–H509 (2015).
Savchenko, A. S. et al. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. Blood 123, 141–148 (2014).
Wu, K. et al. Polyglycerol-amine covered nanosheets target cell-free DNA to attenuate acute kidney injury. Adv. Sci. (Weinh.) 10, e2300604 (2023).
Raup-Konsavage, W. M. et al. Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury. Kidney Int 93, 365–374 (2018).
Jansen, M. P. et al. Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. Kidney Int 91, 352–364 (2017).
Zhuang, S. et al. Targeting P2RX1 alleviates renal ischemia/reperfusion injury by preserving mitochondrial dynamics. Pharmacol. Res. 170, 105712 (2021).
Ma, G. et al. Ribonuclease alleviates hepatic ischemia-reperfusion injury by suppressing excessive cytokine release and TLR3-mediated apoptosis in mice. Cytokine 133, 155178 (2020).
Wang, Y. et al. The RNA receptor RIG-I binding synthetic oligodeoxynucleotide promotes pneumonia survival. JCI Insight 9, e180584 (2024).
Kim, T. H. et al. Anti-bacterial effect of CpG-DNA involves enhancement of the complement systems. Int. J. Mol. Sci. 20, 3397 (2019).
Kim, T. H. et al. CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies. Sci. Rep. 8, 16236 (2018).
Kim, T. H. et al. CpG-DNA induces bacteria-reactive IgM enhancing phagocytic activity against Staphylococcus aureus infection. BMB Rep. 52, 635–640 (2019).
Wu, H. M. et al. CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage. Life Sci. 161, 51–59 (2016).
Wang, G. et al. A study on the protective effects of CpG oligodeoxynucleotide-induced mucosal immunity against lung injury in a mouse acute respiratory distress syndrome model. J. Cell. Physiol. 234, 20118–20127 (2019).
Mathur, S., Walley, K. R. & Boyd, J. H. The Toll-like receptor 9 ligand CPG-C attenuates acute inflammatory cardiac dysfunction. Shock 36, 478–483 (2011).
Leiva-Juarez, M. M. et al. Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir. Eur. J. Pharmacol. 818, 191–197 (2018).
Bode, C., Yang, X. P., Kiu, H. & Klinman, D. M. Suppressive oligodeoxynucleotides promote the development of Th17 cells. PLoS One 8, e67991 (2013).
Tilstra, J. S. et al. B cell-intrinsic TLR9 expression is protective in murine lupus. J. Clin. Invest. 130, 3172–3187 (2020).
Leibler, C. et al. Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus. Nat. Immunol. 23, 1457–1469 (2022).
Suthers, A. N. & Sarantopoulos, S. TLR7/TLR9- and B cell receptor-signaling crosstalk: Promotion of potentially dangerous B Cells. Front. Immunol. 8, 775 (2017).
Yasuda, H. et al. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am. J. Physiol. Ren. Physiol. 294, F1050–F1058 (2008).
Hu, D. et al. Inhibition of Toll-like receptor 9 attenuates sepsis-induced mortality through suppressing excessive inflammatory response. Cell. Immunol. 295, 92–98 (2015).
Plitas, G. et al. Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J. Exp. Med. 205, 1277–1283 (2008).
Esparza, K. et al. Thiostrepton-Nanomedicine, a TLR9 Inhibitor, Attenuates Sepsis-Induced Inflammation in Mice. Med. Inflamm. 2023, 4035516 (2023).
Lohner, R. et al. Toll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsis. Med. Inflamm. 2013, 261049 (2013).
Han, S. J. et al. Selective nanoparticle-mediated targeting of renal tubular Toll-like receptor 9 attenuates ischemic acute kidney injury. Kidney Int 98, 76–87 (2020).
Zheng, H. et al. Depletion of toll-like receptor-9 attenuates renal tubulointerstitial fibrosis after ischemia-reperfusion injury. Front. Cell Dev. Biol. 9, 641527 (2021).
Yayi, H. et al. Toll-like receptor 7 involves the injury in acute kidney ischemia/reperfusion of STZ-induced diabetic rats. Acta Cir. Bras. 31, 448–455 (2016).
Zhu, Q. et al. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system. Antivir. Res 187, 105015 (2021).
Li, M. et al. Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci. Immunol. 6, eabi9007 (2021).
Garcia, G. Jr. et al. Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses. Cell Rep. Med. 4, 101024 (2023).
Humphries, F. et al. A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection. Sci. Immunol. 6, eabi9002 (2021).
Ullah, T. R. et al. Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection. Nat. Commun. 14, 5666 (2023).
Marino, G. et al. STING is redundant for host defense and pathology of COVID-19-like disease in mice. Life Sci. Alliance 6, e202301997 (2023).
Shen, X. et al. cGAS mediates inflammation by polarizing macrophages to M1 phenotype via the mTORC1 Pathway. J. Immunol. 210, 1098–1107 (2023).
Heipertz, E. L., Harper, J. & Walker, W. E. STING and TRIF contribute to mouse sepsis, depending on severity of the disease model. Shock 47, 621–631 (2017).
Wu, B. et al. STING inhibitor ameliorates LPS-induced ALI by preventing vascular endothelial cells-mediated immune cells chemotaxis and adhesion. Acta Pharmacol. Sin. 43, 2055–2066 (2022).
Kobritz, M. et al. Targeting sting to reduce sepsis-induced acute intestinal injury. Surgery 174, 1071–1077 (2023).
Xia, L. et al. H-151 attenuates lipopolysaccharide-induced acute kidney injury by inhibiting the STING-TBK1 pathway. Ren. Fail. 46, 2363591 (2024).
Leng, X. et al. C-176 inhibits macrophage polarization towards M1-subtype and ameliorates LPS induced acute kidney injury. Eur. J. Pharmacol. 984, 177028 (2024).
Tan, C., Xu, F., Xie, Q. & Li, F. Deficiency of cGAS signaling protects against sepsis-associated encephalopathy. Biochem. Biophys. Res. Commun. 577, 38–44 (2021).
Tian, M., Li, F. & Pei, H. The cGAS-STING pathway: A new therapeutic target for ischemia-reperfusion injury in acute myocardial infarction? Biomedicines 12 (2024).
Shen, A. et al. MicroRNA-24-3p alleviates hepatic ischemia and reperfusion injury in mice through the repression of STING signaling. Biochem. Biophys. Res. Commun. 522, 47–52 (2020).
Rech, L. et al. Small molecule STING inhibition improves myocardial infarction remodeling. Life Sci. 291, 120263 (2022).
Hu, Z. et al. The protective effect of H151, a novel STING inhibitor, in renal ischemia-reperfusion-induced acute kidney injury. Am. J. Physiol. Ren. Physiol. 324, F558–F567 (2023).
Zhao, J. et al. Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections. J. Virol. 86, 11416–11424 (2012).
Tamir, H. et al. Induction of innate immune response by TLR3 agonist protects mice against SARS-CoV-2 infection. Viruses 14, 189 (2022).
Hose, L., Schürmann, M. & Sudhoff, H. Upregulation of key factors of viral entry of corona- and influenza viruses upon TLR3-signaling in cells from the respiratory tract and clinical treatment options by 1,8-Cineol. Phytother. Res. 38, 4453–4466 (2024).
Davis, C. G. et al. TLR3 agonist improves survival to secondary pneumonia in a double injury model. J. Surg. Res. 182, 270–276 (2013).
Jiang, W., Sun, R., Wei, H. & Tian, Z. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc. Natl Acad. Sci. USA 102, 17077–17082 (2005).
Zhao, X. et al. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143. Stem Cells 32, 521–533 (2014).
Chen, T. et al. Poly(I:C)-induced mesenchymal stem cells protect the kidney against ischemia/reperfusion injury via the TLR3/PI3K pathway. Front. Med. (Lausanne) 8, 755849 (2021).
Chen, E. et al. Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway. Signal Transduct. Target. Ther. 5, 216 (2020).
Chen, E. et al. Poly(I:C) attenuates myocardial ischemia/reperfusion injury by restoring autophagic function. FASEB J. 36, e22317 (2022).
Khodadadi, H. et al. Cannabidiol modulates cytokine storm in acute respiratory distress syndrome induced by simulated viral infection using synthetic RNA. Cannabis Cannabinoid Res. 5, 197–201 (2020).
Yeh, C. L. et al. Calcitriol attenuates poly(I:C)-induced lung injury in obese mice via modulating toll-like receptor 3- and renin-angiotensin system-associated signal pathways. Int. Immunopharmacol. 128, 111522 (2024).
Gan, T. et al. TLR3 regulated poly I:C-induced neutrophil extracellular traps and acute lung injury partly through p38 MAP kinase. Front. Microbiol. 9, 3174 (2018).
Tian, X. et al. Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria. PLoS One 7, e41879 (2012).
Sharma, D. et al. Poly(I:C) priming exacerbates cecal ligation and puncture-induced polymicrobial sepsis in mice. Inflammation 41, 328–336 (2018).
Wong, J. P. et al. Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine 27, 3481–3483 (2009).
Majde, J. A. et al. Attenuation of the influenza virus sickness behavior in mice deficient in toll-like receptor 3. Brain Behav. Immun. 24, 306–315 (2010).
Huo, C. et al. Lethal influenza A virus preferentially activates TLR3 and triggers a severe inflammatory response. Virus Res. 257, 102–112 (2018).
Leung, Y. H. C. et al. Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice. J. Gen. Virol. 95, 1870–1879 (2014).
Poux, C. et al. A single-stranded oligonucleotide inhibits toll-like receptor 3 activation and reduces influenza A (H1N1) infection. Front. Immunol. 10, 2161 (2019).
Poulas, K., Farsalinos, K. & Zanidis, C. Activation of TLR7 and innate immunity as an efficient method against COVID-19 pandemic: Imiquimod as a potential therapy. Front. Immunol. 11, 1373 (2020).
Angelopoulou, A. et al. Imiquimod – A toll like receptor 7 agonist – Is an ideal option for management of COVID 19. Environ. Res. 188, 109858 (2020).
To, E. E. et al. Intranasal and epicutaneous administration of toll-like receptor 7 (TLR7) agonists provides protection against influenza A virus-induced morbidity in mice. Sci. Rep. 9, 2366 (2019).
Huang, K. et al. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. EBioMedicine 67, 103381 (2021).
Roßmann, L. et al. Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response. Proc. Natl. Acad. Sci. USA. 118, e2103651118 (2021).
Jackson, W. D. et al. TLR7 activation at epithelial barriers promotes emergency myelopoiesis and lung antiviral immunity. Elife 12, e85647 (2023).
Wynn, J. L. et al. Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 112, 1750–1758 (2008).
Van Hoeven, N. et al. A formulated TLR7/8 agonist is a flexible, highly potent and effective adjuvant for pandemic influenza vaccines. Sci. Rep. 7, 46426 (2017).
Hammerbeck, D. M. et al. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats. Antivir. Res 73, 1–11 (2007).
Coch, C. et al. RIG-I activation protects and rescues from lethal influenza virus infection and bacterial superinfection. Mol. Ther. 25, 2093–2103 (2017).
Port, A. et al. Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8. Pharmacol. Res. Perspect. 9, e00842 (2021).
McKinnon, J. E. et al. Enpatoran in COVID-19 pneumonia: Safety and efficacy results from a phase II randomized trial. Clin. Transl. Sci. 16, 2640–2653 (2023).
Stegemann-Koniszewski, S. et al. TLR7 contributes to the rapid progression but not to the overall fatal outcome of secondary pneumococcal disease following influenza A virus infection. J. Innate Immun. 5, 84–96 (2013).
Schwab, L. S. U. et al. Retinoic acid-inducible gene I activation inhibits human respiratory syncytial virus replication in mammalian cells and in mouse and ferret models of infection. J. Infect. Dis. 226, 2079–2088 (2022).
Chiang, C. et al. Sequence-specific modifications enhance the broad-spectrum antiviral response activated by RIG-I agonists. J. Virol. 89, 8011–8025 (2015).
Palermo, E. et al. Virus-like particle – mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection. Front. Cell. Infect. Microbiol. 12, 1079926 (2022).
Lin, L. et al. 5’-Triphosphate-short interfering RNA: Potent inhibition of influenza A virus infection by gene silencing and RIG-I activation. J. Virol. 86, 10359–10369 (2012).
Marx, S. et al. RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection. Mol. Ther. Nucleic Acids 27, 1225–1234 (2022).
Mao, T. et al. A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice. J. Exp. Med. 219, e20211818 (2022).
Wu, W. et al. RIG-I agonist SLR10 promotes macrophage M1 polarization during influenza virus infection. Front. Immunol. 14, 1177624 (2023).
Song, Z. et al. A Short 5’triphosphate RNA nCoV-L induces a broad-spectrum antiviral response by activating RIG-I. Viruses 14, 2451 (2022).
Kesy, J. et al. A short chemically modified dsRNA-binding PNA (dbPNA) inhibits influenza viral replication by targeting viral RNA panhandle structure. Bioconjug. Chem. 30, 931–943 (2019).
Guo, X. et al. Interplay of cGAS with micronuclei: Regulation and diseases. Mutat. Res. Rev. Mutat. Res. 790, 108440 (2022).
Maslove, D. M. et al. Redefining critical illness. Nat. Med. 28, 1141–1148 (2022).
Zhu, L. et al. High level of neutrophil extracellular traps correlates with poor prognosis of severe influenza A infection. J. Infect. Dis. 217, 428–437 (2018).
Zhang, N. et al. Circulating rather than alveolar extracellular deoxyribonucleic acid levels predict outcomes in influenza. J. Infect. Dis. 222, 1145–1154 (2020).
Peters, R. P. et al. Streptococcus pneumoniae DNA load in blood as a marker of infection in patients with community-acquired pneumonia. J. Clin. Microbiol. 47, 3308–3312 (2009).
Muñoz-Almagro, C. et al. DNA bacterial load in children and adolescents with pneumococcal pneumonia and empyema. Eur. J. Clin. Microbiol. Infect. Dis. 30, 327–335 (2011).
Hernández-Beeftink, T. et al. Whole-blood mitochondrial DNA copies are associated with the prognosis of acute respiratory distress syndrome after sepsis. Front. Immunol. 12, 737369 (2021).
Vasilijevic, J. et al. Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients. PLoS Pathog. 13, e1006650 (2017).
Zhang, D. et al. A potential role of microvesicle-containing miR-223/142 in lung inflammation. Thorax 74, 865–874 (2019).
Huckriede, J. et al. Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients. Sci. Rep. 11, 15701 (2021).
Krinsky, N. et al. NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel. J. Thromb. Haemost. 21, 2569–2584 (2023).
Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight 5, e138999, (2020).
de Diego, C. et al. What is the actual relationship between neutrophil extracellular traps and COVID-19 severity? A longitudinal study. Respir. Res. 25, 48 (2024).
Giacconi, R. et al. Blood circulating bacterial DNA in hospitalized old COVID-19 patients. Immun. Ageing 20, 76 (2023).
Kitsios, G. D. et al. Plasma microbial cell-free DNA load is associated with mortality in patients with COVID-19. Respir. Res. 22, 24 (2021).
Lisius, G. et al. Noninvasive diagnosis of secondary infections in COVID-19 by sequencing of plasma microbial cell-free DNA. iScience 26, 108093 (2023).
Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369, 1210–1220 (2020).
Lunjani, N. et al. Higher levels of bacterial DNA in serum associate with severe and fatal COVID-19. Allergy 77, 1312–1314 (2022).
Ikezaki, H., Nomura, H. & Shimono, N. Impact of peripheral mitochondrial DNA level on immune response after COVID-19 vaccination. iScience 26, 107094 (2023).
Scozzi, D. et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight 6, e143299, (2021).
Lu, R. X. Z. et al. Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes. Sci. Adv. 10, eadk0164 (2024).
Shoraka, S., Mohebbi, S. R., Hosseini, S. M. & Zali, M. R. Comparison of plasma mitochondrial DNA copy number in asymptomatic and symptomatic COVID-19 patients. Front. Microbiol. 14, 1256042 (2023).
Shteinfer-Kuzmine, A. et al. Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release. Apoptosis. 29, 2025–2046 (2024).
Tanaka, A. et al. Increased levels of circulating cell-free DNA in COVID-19 patients with respiratory failure. Sci. Rep. 14, 17399 (2024).
Matviichuk, A. et al. HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients. Sci. Rep. 14, 25533 (2024).
Middleton, E. A. et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 136, 1169–1179 (2020).
Feys, S. et al. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study. Lancet Microbe 5, e247–e260 (2024).
Wang, Y. et al. Plasma cell-free RNA characteristics in COVID-19 patients. Genome Res. 32, 228–241 (2022).
Menezes, S. M. et al. Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 condition. Lancet Microbe 5, 100849 (2024).
Chen, W. et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg. Microbes Infect. 9, 469–473 (2020).
Heinrich, F. et al. SARS-CoV-2 blood RNA load predicts outcome in critically Ill COVID-19 patients. Open Forum Infect. Dis. 8, ofab509 (2021).
Moatar, A. I. et al. Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients. Sci. Rep. 13, 13806 (2023).
Bermejo-Martin, J. F. et al. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit. Care 24, 691 (2020).
Rodríguez-Serrano, D. A. et al. Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients. Sci. Rep. 11, 13134 (2021).
Pozzi, A. COVID-19 and mitochondrial non-coding RNAs: New insights from published data. Front. Physiol. 12, 805005 (2021).
Anfossi, S. et al. MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2. Mol. Cancer 23, 235 (2024).
Barberis, E. et al. Circulating exosomes are strongly involved in SARS-CoV-2 infection. Front Mol. Biosci. 8, 632290 (2021).
de Miranda, F. S. et al. Cell-free nuclear and mitochondrial DNA as potential biomarkers for assessing sepsis severity. Biomedicines 12, 933 (2024).
Dwivedi, D. J. et al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit. Care 16, R151 (2012).
Coupland, L. A. et al. Plasma dynamics of neutrophil extracellular traps and cell-free DNA in septic and nonseptic vasoplegic shock: A prospective comparative observational cohort study. Shock 62, 193–200 (2024).
Saukkonen, K. et al. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin. Chem. 54, 1000–1007 (2008).
Hampson, P. et al. Neutrophil dysfunction, immature granulocytes, and cell-free DNA are early biomarkers of sepsis in burn-injured patients: A prospective observational cohort study. Ann. Surg. 265, 1241–1249 (2017).
Clementi, A. et al. The role of cell-free plasma DNA in critically Ill patients with sepsis. Blood Purif. 41, 34–40 (2016).
Jiao, Y. et al. Platelet-derived exosomes promote neutrophil extracellular trap formation during septic shock. Crit. Care 24, 380 (2020).
Xu, F. et al. Cell-free DNA predicts all-cause mortality of sepsis-induced acute kidney injury. Ren. Fail. 46, 2273422 (2024).
Zhang, D. et al. MPO-DNA complexes and cf-DNA in patients with sepsis and their clinical value. Biomedicines 12, 2190 (2024).
Hamaguchi, S. et al. Origin of circulating free DNA in sepsis: Analysis of the CLP mouse model. Med. Inflamm. 2015, 614518 (2015).
Nieman, A. E., Rozemeijer, W., Savelkoul, P. H. M. & Schade, R. P. Bacterial DNA load in Staphylococcus aureus bacteremia is significantly higher in intravascular infections. PLoS One 17, e0266869 (2022).
Chen, H. et al. Blood microbial signatures associated with mortality in patients with sepsis: A pilot study. Heliyon 10, e29572 (2024).
Walton, A. H. et al. Reactivation of multiple viruses in patients with sepsis. PLoS One 9, e98819 (2014).
Cabler, S. S. et al. Viral DNAemia and DNA virus seropositivity and mortality in pediatric sepsis. JAMA Netw. Open 7, e240383 (2024).
Davila, S. et al. Viral DNAemia and immune suppression in pediatric sepsis. Pediatr. Crit. Care Med. 19, e14–e22 (2018).
Simon, D. W. et al. DNA viremia is associated with hyperferritinemia in pediatric sepsis. J. Pediatr. 213, 82–87.e82 (2019).
Di Caro, V. et al. Plasma mitochondrial DNA–a novel DAMP in pediatric sepsis. Shock 45, 506–511 (2016).
Dennhardt, S. et al. Cell-free DNA in patients with sepsis: long term trajectory and association with 28-day mortality and sepsis-associated acute kidney injury. Front. Immunol. 15, 1382003 (2024).
Schäfer, S. T. et al. Mitochondrial DNA: An endogenous trigger for immune paralysis. Anesthesiology 124, 923–933 (2016).
Alpkvist, H. et al. Damage-associated molecular patterns in bacteraemic infection, including a comparative analysis with bacterial DNA, a pathogen-associated molecular pattern. Sci. Rep. 14, 23499 (2024).
Wang, S. et al. Role of extracellular microRNA-146a-5p in host innate immunity and bacterial sepsis. iScience 24, 103441 (2021).
Schneck, E. et al. Plasma DNA and RNA differentially impact coagulation during abdominal sepsis-an explorative study. J. Surg. Res. 210, 231–243 (2017).
Sweeney, T. E. & Khatri, P. Benchmarking sepsis gene expression diagnostics using public data. Crit. Care Med. 45, 1–10 (2017).
Trung, N. T. et al. Circulating miR-147b as a diagnostic marker for patients with bacterial sepsis and septic shock. PLoS One 16, e0261228 (2021).
Dakhlallah, D. A. et al. Circulating extracellular vesicle content reveals de novo DNA methyltransferase expression as a molecular method to predict septic shock. J. Extracell. Vesicles 8, 1669881 (2019).
Hazeldine, J. et al. Traumatic injury is associated with reduced deoxyribonuclease activity and dysregulation of the actin scavenging system. Burns Trauma 9, tkab001 (2021).
Halpern, D. et al. Admission circulating cell-free DNA levels as a prognostic factor in pediatric burns. Biomed. Res. Int. 2022, 5004282 (2022).
Letendre, J. A. & Goggs, R. Measurement of plasma cell-free DNA concentrations in dogs with sepsis, trauma, and neoplasia. J. Vet. Emerg. Crit. Care (San. Antonio) 27, 307–314 (2017).
Itagaki, K. et al. Mitochondrial DNA released by trauma induces neutrophil extracellular traps. PLoS One 10, e0120549 (2015).
McIlroy, D. J. et al. Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery. J. Crit. Care 29, 1133.e1131–1135 (2014).
Tuz, A. A. et al. Stroke and myocardial infarction induce neutrophil extracellular trap release disrupting lymphoid organ structure and immunoglobulin secretion. Nat. Cardiovasc. Res. 3, 525–540 (2024).
Wang, L. et al. Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients. Coron. Artery Dis. 26, 296–300 (2015).
Yang, K. et al. Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition. Eur. Heart J. 45, 1662–1680 (2024).
Kumarswamy, R. et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ. Res. 114, 1569–1575 (2014).
Zhang, L. et al. Circulating MicroRNAs: Biogenesis and clinical significance in acute myocardial infarction. Front. Physiol. 11, 1088 (2020).
Navickas, R. et al. Identifying circulating microRNAs as biomarkers of cardiovascular disease: A systematic review. Cardiovasc. Res. 111, 322–337 (2016).
Li, P. et al. Predictive value of neutrophil extracellular traps components for 28-day all-cause mortality in patients with cardiac arrest: A pilot observational study. Shock 60, 664–670 (2023).
Krenzien, F. et al. Increased cell-free DNA plasma concentration following liver transplantation is linked to portal hepatitis and inferior survival. J. Clin. Med. 9, 1543 (2020).
Liu, Y. et al. Neutrophil extracellular traps regulate HMGB1 translocation and Kupffer Cell M1 polarization during acute liver transplantation rejection. Front. Immunol. 13, 823511 (2022).
Zhang, S. et al. Hydroxychloroquine inhibiting neutrophil extracellular trap formation alleviates hepatic ischemia/reperfusion injury by blocking TLR9 in mice. Clin. Immunol. 216, 108461 (2020).
Yoshino, O. et al. Elevated levels of circulating mitochondrial DNA predict early allograft dysfunction in patients following liver transplantation. J. Gastroenterol. Hepatol. 36, 3500–3507 (2021).
Xu, D. et al. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy. Cell Death Dis. 8, e2983 (2017).
Sigdel, T. K. et al. A rapid noninvasive assay for the detection of renal transplant injury. Transplantation 96, 97–101 (2013).
Nakazawa, D. et al. Histones and neutrophil extracellular traps enhance tubular necrosis and remote organ injury in ischemic AKI. J. Am. Soc. Nephrol. 28, 1753–1768 (2017).
Wu, J. et al. Identification of renal ischemia reperfusion injury subtypes and predictive strategies for delayed graft function and graft survival based on neutrophil extracellular trap-related genes. Front. Immunol. 13, 1047367 (2022).
Gaál Kovalčíková, A. et al. Extracellular DNA concentrations in various aetiologies of acute kidney injury. Sci. Rep. 12, 16812 (2022).
Jansen, M. P. B. et al. Urinary mitochondrial DNA associates with delayed graft function following renal transplantation. Nephrol. Dial. Transplant. 35, 1320–1327 (2020).
Kroneisl, M. et al. Peri-operative kinetics of plasma mitochondrial DNA levels during living donor kidney transplantation. Int. J. Mol. Sci. 24, 13579 (2023).
Sekheri, M., El Kebir, D., Edner, N. & Filep, J. G. 15-Epi-LXA(4) and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation. Proc. Natl Acad. Sci. USA 117, 7971–7980 (2020).
Patel, S. et al. cGAS-STING and MyD88 pathways synergize in Ly6Chi monocyte to promote streptococcus pneumoniae-induced late-stage lung IFNγ production. Front. Immunol. 12, 699702 (2021).
Te Velthuis, A. J. W. et al. Mini viral RNAs act as innate immune agonists during influenza virus infection. Nat. Microbiol. 3, 1234–1242 (2018).
Chiang, J. J. et al. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat. Immunol. 19, 53–62 (2018).
Steinberg, J., Wadenpohl, T. & Jung, S. The endogenous RIG-I ligand is generated in influenza A-virus infected cells. Viruses 13, 1564 (2021).
Wallach, T. et al. Distinct SARS-CoV-2 RNA fragments activate toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia. Front. Immunol. 13, 1066456 (2022).
Kouwaki, T., Nishimura, T., Wang, G. & Oshiumi, H. RIG-I-like receptor-mediated recognition of viral genomic RNA of severe acute respiratory syndrome coronavirus-2 and viral escape from the host innate immune responses. Front. Immunol. 12, 700926 (2021).
Konecna, B. et al. Monocyte exocytosis of mitochondrial danger-associated molecular patterns in sepsis suppresses neutrophil chemotaxis. J. Trauma Acute Care Surg. 90, 46–53 (2021).
Abdullah, Z. et al. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. EMBO J. 31, 4153–4164 (2012).
Pagliuso, A. et al. An RNA-binding protein secreted by a bacterial pathogen modulates RIG-I signaling. Cell Host Microbe 26, 823–835.e811 (2019).
Mi, L. et al. Neutrophil extracellular traps aggravate neuronal endoplasmic reticulum stress and apoptosis via TLR9 after traumatic brain injury. Cell Death Dis. 14, 374 (2023).
